Endogenous opiates and behavior: 2002 (Q35581558)

9 August 2017

1 reference

title

Endogenous opiates and behavior: 2002 (English)

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

31 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

31 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

31 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

31 March 2024

author name string

Richard J. Bodnar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14612197

31 March 2024

Maria M. Hadjimarkou

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14612197

31 March 2024

language of work or name

1 reference

1 August 2003

1 reference

full work available at URL

9 August 2017

number of pages

62

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:S0196978103002663?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

https://api.elsevier.com/content/article/PII:S0196978103002663?httpAccept=text/plain

31 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

31 March 2024

1 reference

9 August 2017

volume

24

1 reference

9 August 2017

issue

8

1 reference

9 August 2017

page(s)

1241-1302

1 reference

RETRACTED: Association of mu-opioid receptor subunit gene and idiopathic generalized epilepsy

9 August 2017

cites work

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1212/WNL.59.5.724

Repeated massage-like stimulation induces long-term effects on nociception: contribution of oxytocinergic mechanisms

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1046/J.1460-9568.2002.02087.X

Mu and delta opioid receptor-like immunoreactivity in the cervical spinal cord of the rat after dorsal rhizotomy or neonatal capsaicin: an analysis of pre- and postsynaptic receptor distributions

1

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Anatomical and functional correlation of the endomorphins with mu opioid receptor splice variants

31 March 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Antinociceptive effects of the essential oil of Croton nepetaefolius on mice

31 March 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effect of morphine-induced antinociception is altered by AF64A-induced lesions on cholinergic neurons in rat nucleus raphe magnus

31 March 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Delta opioid receptor localization in the rat cerebellum

31 March 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Activation of mu-opioid receptors inhibits lordosis behavior in estrogen and progesterone-primed female rats

31 March 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Estrogen modulation of mu-opioid receptor-stimulated [35S]-GTP-gamma-S binding in female rat brain visualized by in vitro autoradiography

31 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The role of delta-opioid receptors in estrogen facilitation of lordosis behavior

31 March 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Brain-derived neurotrophic factor is essential for opiate-induced plasticity of noradrenergic neurons.

31 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Electrical stimulation of nucleus raphe dorsalis changes morphine self-administration and withdrawal symptoms in rats

31 March 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Dextromethorphan potentiates the antinociceptive effects of morphine and the delta-opioid agonist SNC80 in squirrel monkeys

31 March 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Opioids, immunology, and host defenses of intravenous drug abusers

31 March 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Mu and Delta opioid receptors activate the same G proteins in human neuroblastoma SH-SY5Y cells

31 March 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

mu-Opioid receptors: Ligand-dependent activation of potassium conductance, desensitization, and internalization.

31 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Identity of adenylyl cyclase isoform determines the G protein mediating chronic opioid-induced adenylyl cyclase supersensitivity

31 March 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Naloxone increases pain induced by topical capsaicin in healthy human volunteers

31 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effect of single-dose subarachnoid spinal anesthesia on pain and recovery after unilateral percutaneous nephrolithotomy

31 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Opioid control of prolactin secretion in late pregnant rats is mediated by tuberoinfundibular dopamine neurons

31 March 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Age-dependency of analgesia elicited by intraoral sucrose in acute and persistent pain models

31 March 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Novel orphanin FQ/nociceptin transcripts are expressed in human immune cells

31 March 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Age-dependent NOC/oFQ contribution to impaired hypotensive cerebral hemodynamics after brain injury

31 March 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

NOC/oFQ activates PKC and generates superoxide to impair hypotensive cerebrovasodilation after hypoxia/ischemia

31 March 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

NOC/oFQ and NMDA contribute to piglet hypoxic ischemic hypotensive cerebrovasodilation impairment

31 March 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Role of Nociceptin/Orphanin FQ in the physiologic and pathologic control of the cerebral circulation.

31 March 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effects of IV morphine in central pain: a randomized placebo-controlled study

31 March 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Endomorphins 1 and 2 inhibit IL-10 and IL-12 production and innate immune functions, and potentiate NF-kappaB DNA binding in THP-1 differentiated to macrophage-like cells

31 March 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Alcohol-induced c-Fos expression in the Edinger-Westphal nucleus: pharmacological and signal transduction mechanisms

31 March 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Changes in spinal delta and kappa opioid systems in mice deficient in the A2A receptor gene.

31 March 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Quantitative autoradiography of adenosine receptors and NBTI-sensitive adenosine transporters in the brains and spinal cords of mice deficient in the mu-opioid receptor gene.

31 March 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Dextromethorphan and ketamine potentiate the antinociceptive effects of mu- but not delta- or kappa-opioid agonists in a mouse model of acute pain

31 March 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice

31 March 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Sex-specific differences in levels of morphine, morphine-3-glucuronide, and morphine antinociception in rats

31 March 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Evaluation of the Dmt-Tic pharmacophore: conversion of a potent delta-opioid receptor antagonist into a potent delta agonist and ligands with mixed properties

31 March 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The neuropeptide FF analogue, 1DMe, reduces in vivo dynorphin release from the rat spinal cord

31 March 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Sex and rat strain determine sensitivity to kappa opioid-induced antinociception

31 March 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

31 March 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli

31 March 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Deletion of the M5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia

31 March 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effects of beta-endorphin on nasal allergic inflammation

31 March 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Orexin/hypocretin neurons: chemical phenotype and possible interactions with melanin-concentrating hormone neurons

31 March 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Opioid receptors on white blood cells: effect of HIV infection and methadone treatment

31 March 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Rewarding effects of ethanol and cocaine in mu opioid receptor-deficient mice

31 March 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Magnesium increases morphine analgesic effect in different experimental models of pain

31 March 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Expression of calcitonin gene-related peptide, substance P and protein kinase C in cultured dorsal root ganglion neurons following chronic exposure to mu, delta and kappa opiates

31 March 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The fibroblast growth factor receptor is at the site of convergence between mu-opioid receptor and growth factor signaling pathways in rat C6 glioma cells

31 March 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The dorsomedial hypothalamic nucleus and its role in ingestive behavior and body weight regulation: lessons learned from lesioning studies.

31 March 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effect of a mu-opioid receptor-selective antagonist on interleukin-6 fever

31 March 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Role of the nitric oxide pathway in kappa-opioid-induced hypothermia in rats

31 March 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Pain activation of human supraspinal opioid pathways as demonstrated by [11C]-carfentanil and positron emission tomography (PET).

31 March 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Identification of arodyn, a novel acetylated dynorphin A-(1-11) analogue, as a kappa opioid receptor antagonist

31 March 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Vagotomy prevents morphine-induced reduction in Fos-like immunoreactivity in trigeminal spinal nucleus produced after TMJ injury in a sex-dependent manner

31 March 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Sex differences in amino acid release from rostral trigeminal subnucleus caudalis after acute injury to the TMJ region

31 March 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Hepatic Met-enkephalin immunoreactivity is enhanced in primary biliary cirrhosis

31 March 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Up-regulation of central mu-opioid receptors in a model of hepatic encephalopathy: a potential mechanism for increased sensitivity to morphine in liver failure

31 March 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Presynaptic mu-opioid receptors regulate a late step of the secretory process in rat ventral tegmental area GABAergic neurons

31 March 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in mu-opioid receptor knock-out mice.

31 March 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol

31 March 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Lack of the nociceptin receptor does not affect acute or chronic nociception in mice

31 March 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Potentiation of morphine analgesia by BQ123, an endothelin antagonist

31 March 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effects of naloxone benzoylhydrazone on native and recombinant nociceptin/orphanin FQ receptors

31 March 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)amide analogues. 1. In vitro studies.

31 March 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

D-amphetamine-induced behavioral sensitization: effect of lesioning dopaminergic terminals in the medial prefrontal cortex, the amygdala and the entorhinal cortex

31 March 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Desensitization of mu-opioid receptor-evoked potassium currents: initiation at the receptor, expression at the effector

31 March 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The influence of GnRH, oxytocin and vasoactive intestinal peptide on the secretion of beta-endorphin and production of cAMP and cGMP by porcine pituitary cells in vitro

31 March 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice.

31 March 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Synergy between mu opioid ligands: evidence for functional interactions among mu opioid receptor subtypes

31 March 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Acupuncture beyond the endorphin concept?

31 March 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Involvement of activator protein-1 in transcriptional regulation of the human mu-opioid receptor gene

31 March 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Flunitrazepam variably alters morphine, buprenorphine, and methadone lethality in the rat.

31 March 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Interaction of a combination of morphine and ketamine on the nociceptive flexion reflex in human volunteers

31 March 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Developmental changes in opioid peptides and their receptors in Cpe(fat)/Cpe(fat) mice lacking peptide processing enzyme carboxypeptidase E.

31 March 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Galanin modulates the activity of proopiomelanocortin neurons in the isolated mediobasal hypothalamus of the male rat.

31 March 2024

74

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Antagonism of the antinociceptive and discriminative stimulus effects of heroin and morphine by 3-methoxynaltrexone and naltrexone in rhesus monkeys

31 March 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The effects of heroin on prolactin levels in male rhesus monkeys: use of cumulative-dosing procedures

31 March 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Beta-endorphin modulation of lymphocyte proliferation: effects of ethanol

31 March 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Group differences in pain modulation: pain-free women compared to pain-free men and to women with TMD.

31 March 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Sympathoinhibitory action of nociceptin in the rat spinal cord

31 March 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Involvement of the neuropeptide orphanin FQ/nociceptin in kainate and kindling seizures and epileptogenesis

31 March 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Involvement of the neuropeptide nociceptin/orphanin FQ in kainate seizures.

31 March 2024

81

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Up-regulation of ORL-1 receptors in spinal tissue of allodynic rats after sciatic nerve injury.

31 March 2024

82

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Convulsant activity of a non-peptidic delta-opioid receptor agonist is not required for its antidepressant-like effects in Sprague-Dawley rats

31 March 2024

83

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Nonpeptidic delta-opioid receptor agonists reduce immobility in the forced swim assay in rats

31 March 2024

84

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice

31 March 2024

85

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Ethological analysis of morphine withdrawal with different dependence programs in male mice

31 March 2024

86

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Use of noninvasive dental dolorimetry to evaluate analgesic effects of intravenous and intrathecal administration of morphine in anesthetized dogs

31 March 2024

87

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Anger and pain sensitivity in chronic low back pain patients and pain-free controls: the role of endogenous opioids.

31 March 2024

89

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The relationship between resting blood pressure and acute pain sensitivity in healthy normotensives and chronic back pain sufferers: the effects of opioid blockade

31 March 2024

90

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Factors associated with non-fatal heroin overdose: assessing the effect of frequency and route of heroin administration.

31 March 2024

91

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Combined blockade of both micro - and kappa-opioid receptors prevents the acute orexigenic action of Agouti-related protein

31 March 2024

92

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Experimental conditions for the continuous subcutaneous infusion of four central analgesics in rats

31 March 2024

93

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Increase in adenosine sensitivity in the nucleus accumbens following chronic morphine treatment

31 March 2024

94

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

[Phe(1)Psi(CH(2)-NH)Gly(2)]NC(1-13)NH(2) does not antagonize orphaninFQ/nociceptin-induced prolactin release

31 March 2024

95

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Endogenous opioid effects on motoneuron pool excitability: potential analgesic effect of acute exercise

31 March 2024

96

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Reduced tolerance to the anti-hyperalgesic effect of methadone in comparison to morphine in a rat model of mononeuropathy

31 March 2024

97

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Differential antinociception by morphine and methadone in two sub-strains of Sprague-Dawley rats and its potentiation by dextromethorphan

31 March 2024

98

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Time-dependent descending facilitation from the rostral ventromedial medulla maintains, but does not initiate, neuropathic pain.

31 March 2024

99

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Molecular components of tolerance to opiates in single hippocampal neurons

31 March 2024

100

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effect of single and repeated methamphetamine treatment on neurotransmitter release in substantia nigra and neostriatum of the rat.

31 March 2024

101

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Comparison of the discriminative and neuroendocrine effects of centrally penetrating kappa-opioid agonists in rhesus monkeys

31 March 2024

102

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Cannabinoid-induced stimulation of motor activity in planaria through an opioid receptor-mediated mechanism

31 March 2024

103

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Regulation of nociceptin/orphanin FQ gene expression in astrocytes by ceramide

31 March 2024

104

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Inflammatory mediators increase the expression of nociceptin/orphanin FQ in rat astrocytes in culture

31 March 2024

105

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The melanocortin receptor agonist MTII augments the rewarding effect of amphetamine in ad-libitum-fed and food-restricted rats

31 March 2024

106

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Cold stress alters Mytilus edulis pedal ganglia expression of mu opiate receptor transcripts determined by real-time RT-PCR and morphine levels

31 March 2024

107

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Interaction between neuropeptide FF and opioids in the ventral tegmental area in the behavioral response to novelty

31 March 2024

108

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Dorsal and median raphe serotonergic system lesion does not alter the opiate withdrawal syndrome

31 March 2024

109

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

[Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.

31 March 2024

110

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias

31 March 2024

111

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Striatal tachykinin and enkephalin mRNAs are normalized by serotonin2 and NMDA manipulation following dopamine depletion

31 March 2024

112

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Unwanted effects of morphine-6-glucoronide and morphine

31 March 2024

113

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Opioid receptor-mediated effects of interleukin-2 on the [Ca2+]i transient and contraction in isolated ventricular myocytes of the rat

31 March 2024

114

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Pretreatment with midazolam suppresses morphine withdrawal response in mice and rats

31 March 2024

115

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Scientific bases of acupuncture analgesia.

31 March 2024

116

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Dexamethasone reduces morphine-induced Straub reaction in mice

31 March 2024

117

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Beta-endorphin fragments (DT gamma E and DE gamma E) reduce opiate withdrawal in guinea pig ileum.

31 March 2024

118

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Endomorphin-1 analogues containing beta-proline are mu-opioid receptor agonists and display enhanced enzymatic hydrolysis resistance

31 March 2024

119

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse?

31 March 2024

120

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Augmentation of drug reward by chronic food restriction: behavioral evidence and underlying mechanisms.

31 March 2024

121

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Intravenous cocaine and heroin self-administration in rats selectively bred for differential saccharin intake: phenotype and sex differences

31 March 2024

122

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Differential regulation of GAD67, enkephalin and dynorphin mRNAs by chronic-intermittent L-dopa and A2A receptor blockade plus L-dopa in dopamine-denervated rats.

31 March 2024

123

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effect of morphine on sympathetic nerve activity in humans

31 March 2024

124

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The combination of low dose of naloxone and morphine in PCA does not decrease opioid requirements in the postoperative period

31 March 2024

125

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Inhibition of protein kinase C but not protein kinase A attenuates morphine withdrawal excitation of rat hypothalamus-pituitary-adrenal axis

31 March 2024

126

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Role of nitric oxide in mediating vasodilator responses to opioid peptides in the rat.

31 March 2024

127

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

31 March 2024

The anorexia of ageing

128

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Potentially functional polymorphism in the promoter region of prodynorphin gene may be associated with protection against cocaine dependence or abuse

31 March 2024

129

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effects of nociceptin (13-17) in pain modulation at supraspinal level in mice

31 March 2024

130

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Hypersensitivity of spinothalamic tract neurons associated with diabetic neuropathic pain in rats

31 March 2024

131

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Functional mu opioid receptors are reduced in the spinal cord dorsal horn of diabetic rats

31 March 2024

132

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Evaluation of the permeation characteristics of a model opioid peptide, H-Tyr-D-Ala-Gly-Phe-D-Leu-OH (DADLE), and its cyclic prodrugs across the blood-brain barrier using an in situ perfused rat brain model

31 March 2024

133

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

[Nphe1]nociceptin(1-13)-NH2 antagonizes nociceptin-induced hypotension, bradycardia, and hindquarters vasodilation in the anesthetized rat.

31 March 2024

134

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

DREAM is a critical transcriptional repressor for pain modulation

31 March 2024

135

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Identification and ranking of genetic and laboratory environment factors influencing a behavioral trait, thermal nociception, via computational analysis of a large data archive

31 March 2024

136

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Spinal lamina I neurones that express neurokinin 1 receptors: II. Electrophysiological characteristics, responses to primary afferent stimulation and effects of a selective mu-opioid receptor agonist

31 March 2024

137

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Gender and pain upon movement are associated with the requirements for postoperative patient-controlled iv analgesia: a prospective survey of 2,298 Chinese patients

31 March 2024

138

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Nociceptin/orphanin FQ modulation of ionic conductances in rat basal forebrain neurons

31 March 2024

139

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

[Nphe(1)]N/OFQ-(1-13)-NH(2) is a competitive and selective antagonist at nociceptin/orphanin FQ receptors mediating K(+) channel activation in rat periaqueductal gray slices

31 March 2024

140

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Change of hyperexcitability of hippocampus by cyclosporin A and its modulatory action by fentanyl

31 March 2024

141

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

M2 muscarinic receptor of spinal cord mediated increase of nNOS expression in locus coeruleus during morphine withdrawal

31 March 2024

142

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Inhibition of mu and delta opioid receptor ligand binding by the peptide aldehyde protease inhibitor, leupeptin

31 March 2024

143

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Modulation of noradrenergic and serotonergic transmission by noxious stimuli and intrathecal morphine differs in the dorsal raphe nucleus of anesthetized rat: in vivo voltammetric studies

31 March 2024

144

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Reversal of stress- and CRF-induced anorexia in rats by the synthetic nociceptin/orphanin FQ receptor agonist, Ro 64-6198.

31 March 2024

146

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effect of selective blockade of mu(1) or delta opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats

31 March 2024

147

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Pharmacological characterization of the nociceptin receptor which mediates reduction of alcohol drinking in rats

31 March 2024

148

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Chronic opiate exposure in the male rat adversely affects fertility

31 March 2024

149

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Gender-linked differences in the expression of physical dependence in the rat.

31 March 2024

150

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Role of steroids in sex differences in morphine-induced analgesia: activational and organizational effects

31 March 2024

151

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Autoradiography of opioid and ORL1 ligands in opioid receptor triple knockout mice

31 March 2024

152

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Eating elicited by orexin-a, but not melanin-concentrating hormone, is opioid mediated

31 March 2024

153

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Evidence that intermittent, excessive sugar intake causes endogenous opioid dependence

31 March 2024

154

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Regulation of dynorphin gene expression by kappa-opioid agonist treatment.

31 March 2024

155

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Chronic cocaine increases kappa-opioid receptor density: lack of effect by selective dopamine uptake inhibitors

31 March 2024

156

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Lack of involvement of mu(1) opioid receptors in dermorphin-induced inhibition of hypoxic and hypercapnic ventilation in rat pups

31 March 2024

157

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Intravenous buprenorphine self-administration by detoxified heroin abusers

31 March 2024

159

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Cellular basis for the effects of substance P in the periaqueductal gray and dorsal raphe nucleus.

31 March 2024

160

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Lack of reward and locomotor stimulation induced by heroin in mu-opioid receptor-deficient mice.

31 March 2024

161

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Pharmacological manipulations of the pedunculopontine tegmental nucleus in the rat reduce self-administration of both nicotine and cocaine

31 March 2024

162

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effects of bremazocine on self-administration of smoked cocaine base and orally delivered ethanol, phencyclidine, saccharin, and food in rhesus monkeys: a behavioral economic analysis

31 March 2024

163

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

No DREAM, No pain. Closing the spinal gate

31 March 2024

164

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Comparison of intrathecal fentanyl and diamorphine in addition to bupivacaine for caesarean section under spinal anaesthesia

31 March 2024

165

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Cocaine- and amphetamine-regulated transcript peptide projections in the ventral midbrain: colocalization with gamma-aminobutyric acid, melanin-concentrating hormone, dynorphin, and synaptic interactions with dopamine neurons

31 March 2024

166

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Recombinant mu-delta receptor as a marker of opiate abuse

31 March 2024

167

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Identification of a fourth opioid core sequence in a prodynorphin cDNA cloned from the brain of the amphibian, Bufo marinus: deciphering the evolution of prodynorphin and proenkephalin

31 March 2024

168

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Differential effects of the dopamine D2/D3 receptor antagonist sulpiride on self-administration of morphine into the ventral tegmental area or the nucleus accumbens

31 March 2024

169

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Role of protein kinase C in control of ethanol-modulated beta-endorphin release from hypothalamic neurons in primary cultures

31 March 2024

170

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Central 5-HT(4) receptors and dopamine-dependent motor behaviors: searching for a functional role

31 March 2024

171

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Antipruritic and antihyperalgesic actions of loperamide and analogs

31 March 2024

172

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Lithium inhibits the development of physical dependence to clonidine in mice

31 March 2024

173

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The biochemical bases for reward. Implications for the placebo effect.

31 March 2024

174

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Attenuation of spontaneous opiate withdrawal in mice by the anandamide transport inhibitor AM404.

31 March 2024

175

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Motivational effects mu- and kappa-opioid agonists following acute and chronic restraint stress: involvement of dopamine D(1) and D(2) receptors

31 March 2024

176

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Influence of acute or repeated restraint stress on morphine-induced locomotion: involvement of dopamine, opioid and glutamate receptors

31 March 2024

177

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The 5-HT(1A) receptor agonist F 13640 attenuates mechanical allodynia in a rat model of trigeminal neuropathic pain

31 March 2024

178

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Morphine, cocaine and antidepressant induced motivational activity and midbrain dopaminergic neurotransmission.

31 March 2024

179

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Heroin sensitization as mapped by c-Fos immunoreactivity in the rat striatum

31 March 2024

180

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Co-release of noradrenaline and dopamine in the prefrontal cortex after acute morphine and during morphine withdrawal

31 March 2024

182

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Orphanin FQ inhibits GnRH secretion from rat hypothalamic fragments but not GT1-7 neurons

31 March 2024

183

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Regulation of mu-opioid receptors, G-protein-coupled receptor kinases and beta-arrestin 2 in the rat brain after chronic opioid receptor antagonism.

31 March 2024

184

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Myocardial preconditioning factors evoke mesenteric ischemic tolerance via opioid receptors and K(ATP) channels

31 March 2024

185

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The effect of chronic ethanol consumption and withdrawal on mu-opioid and dopamine D(1) and D(2) receptor density in Fawn-Hooded rat brain

31 March 2024

186

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

'Knock-down' of spinal CB1 receptors produces abnormal pain and elevates spinal dynorphin content in mice

31 March 2024

187

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Activation of spinal ORL-1 receptors prevents acute cutaneous neurogenic inflammation: role of nociceptin-induced suppression of primary afferent depolarization

31 March 2024

188

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Analyzing the evolution of the opioid/orphanin gene family

31 March 2024

189

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Beta-endorphin cells in the arcuate nucleus: projections to the supraoptic nucleus and changes in expression during pregnancy and parturition

31 March 2024

190

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The importance of oxytocin mechanisms in the control of mouse parturition

31 March 2024

191

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Neurons with mu opioid receptors interact indirectly with enkephalin-containing neurons in the rat dentate gyrus

31 March 2024

192

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Mu opioid receptors are in discrete hippocampal interneuron subpopulations

31 March 2024

193

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Alpha1b-adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates

31 March 2024

194

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Sexually dimorphic effects of morphine and MK-801: sex steroid-dependent and -independent mechanisms

31 March 2024

195

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Antinociceptive effects of the selective delta opioid agonist SNC80 alone and in combination with mu opioids in the squirrel monkey titration procedure

31 March 2024

196

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Can single dose preoperative intrathecal morphine sulfate provide cost-effective postoperative analgesia and patient satisfaction during radical prostatectomy in the current era of cost containment?

31 March 2024

198

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Alterations in food intake elicited by GABA and opioid agonists and antagonists administered into the ventral tegmental area region of rats

31 March 2024

199

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Neuroanatomical and psychopharmacological evidence for interaction between opioid and GABAergic neural pathways in the modulation of fear and defense elicited by electrical and chemical stimulation of the deep layers of the superior colliculus and d

31 March 2024

200

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Chronic morphine treatment inhibits opioid receptor desensitization and internalization.

31 March 2024

201

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Failure of intravenous morphine to serve as an effective instrumental reinforcer in dopamine D2 receptor knock-out mice.

31 March 2024

202

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Chronic morphine-induced changes in mu-opioid receptors and G proteins of different subcellular loci in rat brain

31 March 2024

204

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

alpha(2C)-Adrenergic receptors mediate spinal analgesia and adrenergic-opioid synergy

31 March 2024

205

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Withdrawal from dependence upon butorphanol uniquely increases kappa(1)-opioid receptor binding in the rat brain

31 March 2024

206

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Acute and chronic morphine treatments and morphine withdrawal differentially regulate GRK2 and GRK5 gene expression in rat brain

31 March 2024

207

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Morphine-induced enhancement in the granulocyte response to thioglycollate administration in the rat.

31 March 2024

208

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Cocaine modulates mu-opioid receptor mRNA but not c-fos mRNA levels in primary cortical astrocytes

31 March 2024

209

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Centrally acting agents and visceral sensitivity

31 March 2024

211

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Heroin-assisted treatment as a response to the public health problem of opiate dependence.

31 March 2024

212

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Discrimination of morphine- and haloperidol-induced muscular rigidity and akinesia/catalepsy in simple tests in rats

31 March 2024

213

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Neutral endopeptidase knockout induces hyperalgesia in a model of visceral pain, an effect related to bradykinin and nitric oxide

31 March 2024

214

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Repeated alcohol: behavioral sensitization and alcohol-heightened aggression in mice

31 March 2024

215

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Pavlovian conditioning of opioid and nonopioid pain inhibitory mechanisms in humans

31 March 2024

216

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Colocalization of progesterone receptors in parvicellular dynorphin neurons of the ovine preoptic area and hypothalamus

31 March 2024

217

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effects of laterodorsal tegmentum excitotoxic lesions on behavioral and dopamine responses evoked by morphine and d-amphetamine

31 March 2024

218

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Opiate sensitivity test in patients with stereotypic movement disorder and trichotillomania

31 March 2024

219

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal.

31 March 2024

220

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effects of acute alcohol intoxication on pituitary-gonadal axis hormones, pituitary-adrenal axis hormones, beta-endorphin and prolactin in human adults of both sexes

31 March 2024

221

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Therapeutic receptor targets of ischemic preconditioning

31 March 2024

222

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Response of neurons in the thalamic nucleus submedius (Sm) to noxious stimulation and electrophysiological identification of on- and off-cells in rats

31 March 2024

223

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Basolateral amygdala inactivation abolishes conditioned stimulus- and heroin-induced reinstatement of extinguished heroin-seeking behavior in rats

31 March 2024

224

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma

31 March 2024

225

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Preprodynorphin-, preproenkephalin-, preprotachykinin A- and preprotachykinin B-immunoreactive neurons in the accumbens nucleus and olfactory tubercle: double-immunofluorescence analysis

31 March 2024

227

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Characterization of the discriminative stimulus effects of buprenorphine in pigeons

31 March 2024

228

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Obesity and the polycystic ovary syndrome

31 March 2024

230

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Role of mu-opioid receptors in insulin release in the presence of inhibitory and excitatory secretagogues

31 March 2024

231

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Pronociceptive effects of spinal dynorphin promote cannabinoid-induced pain and antinociceptive tolerance

31 March 2024

232

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Dynorphin-independent spinal cannabinoid antinociception

31 March 2024

233

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Sustained morphine exposure induces a spinal dynorphin-dependent enhancement of excitatory transmitter release from primary afferent fibers.

31 March 2024

234

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Glycosylated phosducin-like protein long regulates opioid receptor function in mouse brain

31 March 2024

235

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Ultrastructural localization of enkephalin and mu-opioid receptors in the rat ventral tegmental area

31 March 2024

236

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Do endogenous opioids contribute to the bradycardia of rats with obstructive cholestasis?

31 March 2024

237

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The analgesic drug tramadol prevents the effect of surgery on natural killer cell activity and metastatic colonization in rats

31 March 2024

238

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Central injections of nocistatin or its C-terminal hexapeptide exert anxiogenic-like effect on behaviour of mice in the plus-maze test

31 March 2024

239

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Blockade effect of mu and kappa opioid antagonists on the anti-nociception induced by intra-periaqueductal grey injection of oxytocin in rats

31 March 2024

240

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Decrease in basal dopamine levels in the nucleus accumbens shell during daily drug-seeking behaviour in rats

31 March 2024

241

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Nitric oxide mediation of morphine-induced place preference in the nucleus accumbens of rat.

31 March 2024

242

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors.

31 March 2024

243

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The role of descending fibers from the rostral ventromedial medulla in opioid analgesia in rats

31 March 2024

244

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Synthesis and opioid activity of new fentanyl analogs.

31 March 2024

245

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Opioid receptor blockade in rat nucleus tractus solitarius alters amygdala dynorphin gene expression

31 March 2024

246

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Alpha(2A)-adrenergic receptors are present in mu-opioid receptor containing neurons in rat medial nucleus tractus solitarius

31 March 2024

247

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Antagonism of alpha 3 beta 4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administration

31 March 2024

248

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Mu-opioid receptor down-regulation and tolerance are not equally dependent upon G-protein signaling

31 March 2024

249

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Treatment of heroin (diamorphine) addiction: current approaches and future prospects

31 March 2024

250

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB(1) receptor binding and mRNA levels

31 March 2024

251

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Quantitative autoradiographic mapping of opioid receptors in the brain of delta-opioid receptor gene knockout mice

31 March 2024

252

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Attenuation of pain in a randomized trial by suppression of peripheral nociceptive activity in the immediate postoperative period

31 March 2024

253

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Herpes vector-mediated expression of proenkephalin reduces bone cancer pain

31 March 2024

254

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The presence of delta and mu-, but not kappa or ORL(1) receptors in bovine pinealocytes

31 March 2024

255

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Comparison of the effect of intrathecal endomorphin-1 and endomorphin-2 on spinal cord excitability in rats

31 March 2024

256

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Predictive factors of persisting illicit drug use in hospitalized heroin addicts.

31 March 2024

257

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Opioid-insensitive hypoalgesia to mechanical stimuli at sites ipsilateral and contralateral to experimental muscle pain in human volunteers

31 March 2024

258

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Opioids and attachment in rhesus macaque (Macaca mulatta) abusive mothers

31 March 2024

259

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The effect of fluvoxamine and sertraline on the opioid withdrawal syndrome: a combined in vivo cerebral microdialysis and behavioural study

31 March 2024

260

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Endomorphin-1 and -2 immunoreactive cells in the hypothalamus are labeled by fluoro-gold injections to the ventral tegmental area

31 March 2024

261

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Opioid rotation in the treatment of joint pain. A review of 67 cases

31 March 2024

262

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Subdiaphragmatic vagal afferent innervation in activation of an opioidergic antinociceptive system in response to colorectal distension in rats

31 March 2024

263

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Morphine administration selectively facilitates social play in common marmosets

31 March 2024

264

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Endogenous morphine modulates acute thermonociception in mice

31 March 2024

265

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Opioid agonists inhibit excitatory neurotransmission in ganglia and at the neuromuscular junction in Guinea pig gallbladder

31 March 2024

266

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Regulation of dihydropyridine-sensitive Ca(2+) channels during naloxone-induced opioid supersensitivity in rats

31 March 2024

267

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

No detectable analgesic effects in the formalin test even with one million bovine adrenal chromaffin cells.

31 March 2024

268

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Opioid signalling in the rat rostral ventrolateral medulla

31 March 2024

270

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Differences in gastroprotective processes in 6- to 8- and 14- to 16-week-old rats

31 March 2024

271

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Feeding induced by food deprivation is differentially reduced by G-protein alpha-subunit antisense probes in rats

31 March 2024

272

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Mu-receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man.

31 March 2024

273

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Probing opioid receptor interactions with azacycloalkane amino acids. Synthesis of a potent and selective ORL1 antagonist

31 March 2024

274

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Pharmacokinetic differences of morphine and morphine-glucuronides are reflected in locomotor activity

31 March 2024

275

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Elevated plasma nociceptin level in patients with Wilson disease

31 March 2024

276

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Sevoflurane suppresses noxious stimulus-evoked expression of Fos-like immunoreactivity in the rat spinal cord via activation of endogenous opioid systems

31 March 2024

277

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Chronic morphine treatment alters endogenous opioid control of hippocampal mossy fiber synaptic transmission

31 March 2024

278

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Comparison of the binding of [(3)H]nociceptin/orphaninFQ(1-13)NH(2), [(3)H]nociceptin/orphaninFQ(1-17)OH and [(125)I]Tyr(14)nociceptin/orphaninFQ(1-17)OH to recombinant human and native rat cerebrocortical nociceptin/orphanin FQ receptors.

31 March 2024

279

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Characterisation of the non-peptide nociceptin receptor agonist, Ro64-6198 in Chinese hamster ovary cells expressing recombinant human nociceptin receptors

31 March 2024

280

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Antiapoptotic and cytotoxic properties of delta opioid peptide [D-Ala(2),D-Leu(5)]enkephalin in PC12 cells

31 March 2024

282

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Selective reward deficit in mice lacking beta-endorphin and enkephalin.

31 March 2024

283

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization

31 March 2024

284

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Analgesic effects of dextromethorphan and morphine in patients with chronic pain

31 March 2024

285

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Delta- and kappa-opioid receptors in the caudal midline medulla mediate haemorrhage-evoked hypotension

31 March 2024

287

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Morphine promotes autonomic learning

31 March 2024

288

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Metamizol potentiates morphine antinociception but not constipation after chronic treatment.

31 March 2024

289

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Efficacy of naltrexone on acetylcholine-induced alloknesis in atopic eczema

31 March 2024

290

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

A combined pharmacological and genetic approach to investigate the role of orphanin FQ in learning and memory.

31 March 2024

291

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The effects of beta-endorphin (beta-END) on cardiovascular and behavioral dynamics in conscious rats

31 March 2024

292

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Plasma catecholamines, serotonin and their metabolites and beta-endorphin of winter swimmers during one winter. Possible correlations to psychological traits

31 March 2024

293

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Different endogenous opioid effects on delta- and mu-receptor subtypes in antral and duodenal motility of conscious dogs

31 March 2024

295

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Defensive behavior and hippocampal cell proliferation: differential modulation by naltrexone during stress

31 March 2024

296

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The role of alpha2-adrenoceptors in the modulatory effects of morphine on seizure susceptibility in mice

31 March 2024

297

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The involvement of endogenous opioids and nitricoxidergic pathway in the anticonvulsant effects of foot-shock stress in mice

31 March 2024

298

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The additive effect of opioids and nitric oxide in increasing pentylenetetrazole-induced seizure threshold in cholestatic mice

31 March 2024

299

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

TNP-ATP, a potent P2X3 receptor antagonist, blocks acetic acid-induced abdominal constriction in mice: comparison with reference analgesics

31 March 2024

300

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Further characterization of preproenkephalin mRNA-containing cells in the rodent globus pallidus

31 March 2024

301

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Inhibition of hematopoietic progenitor cell growth by Tyr-MIF, an endogenous opiate modulator, and its degradation products

31 March 2024

302

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Increase of beta-endorphin biosynthesis in the adrenal gland of streptozotocin-induced diabetic rats

31 March 2024

303

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Morphine induces apoptosis of human microglia and neurons

31 March 2024

304

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Regulation of mouse kappa opioid receptor gene expression by different 3'-untranslated regions and the effect of retinoic acid

31 March 2024

305

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Inhibition of spinal protein kinase Calpha expression by an antisense oligonucleotide attenuates morphine infusion-induced tolerance

31 March 2024

306

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Characteristics of electroacupuncture-induced analgesia in mice: variation with strain, frequency, intensity and opioid involvement

31 March 2024

307

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The local environment at the cytoplasmic end of TM6 of the mu opioid receptor differs from those of rhodopsin and monoamine receptors: introduction of an ionic lock between the cytoplasmic ends of helices 3 and 6 by a L6.30(275)E mutation inactivate

31 March 2024

308

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Acute antinociceptive tolerance and unidirectional cross-tolerance to endomorphin-1 and endomorphin-2 given intraventricularly in the rat

31 March 2024

309

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Subjects with major depression or bipolar disorder show reduction of prodynorphin mRNA expression in discrete nuclei of the amygdaloid complex.

31 March 2024

310

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effects of electroacupuncture on the mechanical allodynia in the rat model of neuropathic pain

31 March 2024

311

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Kappa-opioid receptor model in a phospholipid bilayer: molecular dynamics simulation

31 March 2024

312

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Molecular mechanisms of analgesia induced by opioids and ethanol: is the GIRK channel one of the keys?

31 March 2024

313

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Clinical pharmacology of opioids for pain

31 March 2024

314

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Modulation of kappa-opioidergic systems on mecamylamine-precipitated nicotine-withdrawal aversion in rats

31 March 2024

315

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Gastric acid secretion stimulated by centrally injected nociceptin in urethane-anesthetized rats

31 March 2024

316

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Met-enkephalin and preproenkephalin mRNA changes in the striatum of the nicotine abstinence mouse

31 March 2024

317

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Stress hormones enhance retrieval of fear conditioning acquired either one day or many months before

31 March 2024

318

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Active heroin administration induces specific genomic responses in the nucleus accumbens shell.

31 March 2024

319

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Neutral endopeptidase activity is not elevated in serum in children with cholestatic liver disease: a unique role of aminopeptidase-m in sequential hydrolysis of peptides

31 March 2024

320

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Opioid receptor blockade eliminates mood effects of aerobic gymnastics

31 March 2024

321

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Analgesic and anti-inflammatory effects of A-286501, a novel orally active adenosine kinase inhibitor

31 March 2024

322

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The NK1 receptor mediates both the hyperalgesia and the resistance to morphine in mice lacking noradrenaline

31 March 2024

323

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

NO synthase inhibitors attenuate locus coeruleus catecholamine metabolism and behavior induced by morphine withdrawal

31 March 2024

324

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Comparison of morphine alone with morphine plus clonidine for postoperative patient-controlled analgesia

31 March 2024

325

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effects of cocaine on c-fos and preprodynorphin mRNA levels in intact and ovariectomized Fischer rats

31 March 2024

326

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Opioid peptides endomorphin-1 and endomorphin-2 in the immune system in humans and in a rodent model of inflammation

31 March 2024

327

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

ERK MAP kinase activation in superficial spinal cord neurons induces prodynorphin and NK-1 upregulation and contributes to persistent inflammatory pain hypersensitivity.

31 March 2024

328

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Nociceptin/orphanin FQ inhibits capsaicin-induced guinea-pig airway contraction through an inward-rectifier potassium channel

31 March 2024

329

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The sympathetic nervous system is involved in the inhibitory effect of morphine on the colon motility in rats

31 March 2024

330

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Occurrence, co-occurrence and topographic distribution of choline acetyl transferase, Met-enkephalin and neurotensin in the stellate ganglion of the cat.

31 March 2024

331

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Opioid circuits originating from the nucleus paragigantocellularis and their potential role in opiate withdrawal

31 March 2024

332

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Morphine for the relief of breathlessness in patients with chronic heart failure--a pilot study.

31 March 2024

333

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Attenuation of acute morphine withdrawal in the neonatal rat by the competitive NMDA receptor antagonist LY235959.

31 March 2024

334

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Lack of association of a single-nucleotide polymorphism of the mu-opioid receptor gene with anxiety-related traits: results from a cross-sectional study of adults and a longitudinal study of children.

31 March 2024

335

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

A comparison of the remifentanil and fentanyl adverse effect profile in a multicenter phase IV study

31 March 2024

336

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Impact of ageing on the antinociceptive effect of reference analgesics in the Lou/c rat

31 March 2024

337

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effects of full-thickness burns on nociceptor sensitization in anesthetized rats

31 March 2024

338

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The effect of clonidine on the naltrexone-induced withdrawal response in morphine-treated guinea-pigs

31 March 2024

339

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Perinatal undernutrition: changes in brain opiate receptor density

31 March 2024

340

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

No pain, no gain: clinical excellence and scientific rigour--lessons learned from IA morphine

31 March 2024

342

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Constitutive activation of the opioid receptor-like (ORL1) receptor by mutation of Asn133 to tryptophan in the third transmembrane region

31 March 2024

343

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Influence of GnRH agonist and neural antagonists on stress-blockade of LH and prolactin surges induced by 17beta-estradiol in ovariectomized rats

31 March 2024

344

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Delta-opioid receptor antagonists as a new concept for central acting antitussive drugs

31 March 2024

345

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Nociceptin/orphanin FQ modulates the cardiovascular, but not renal, responses to stress in spontaneously hypertensive rats

31 March 2024

346

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Distribution of beta-endorphin and substance P in the shoulder joint of the dog before and after a low impact exercise programme

31 March 2024

347

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Role of nitric oxide in the rat hippocampal CA1 area on morphine-induced conditioned place preference

31 March 2024

348

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Endomorphins, Met-enkephalin, Tyr-MIF-1, and the P-glycoprotein efflux system

31 March 2024

349

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents

31 March 2024

350

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Intracerebroventricular morphine produces antinociception by evoking gamma-aminobutyric acid release through activation of 5-hydroxytryptamine 3 receptors in the spinal cord

31 March 2024

351

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Immunological challenge modulates brain orphanin FQ/nociceptin and nociceptive behavior

31 March 2024

352

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Opioid modulation of taste hedonics within the ventral striatum.

31 March 2024

353

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The neuroscience of natural rewards: relevance to addictive drugs.

31 March 2024

354

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Baclofen prevents morphine withdrawal irrespective of seasonal variation

31 March 2024

355

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Presynaptic suppression of dorsal horn inhibitory transmission by mu-opioid receptors

31 March 2024

356

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Genetic variation in morphine analgesic tolerance: a survey of 11 inbred mouse strains

31 March 2024

357

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependence

31 March 2024

358

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Role of spinal nitric oxide in the inhibitory effect of [D-Pen2, D-Pen5]-enkephalin on ascending dorsal horn neurons in normal and diabetic rats

31 March 2024

359

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The role of nitric oxide in the proconvulsant effect of delta-opioid agonist SNC80 in mice

31 March 2024

360

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The effects of adenosine receptor agonists and antagonists on morphine state-dependent memory of passive avoidance

31 March 2024

361

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency?

31 March 2024

362

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Opioid tolerance-in search of the holy grail

31 March 2024

363

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Exploring the opioid system by gene knockout

31 March 2024

364

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Sympathetic neural activation evoked by mu-receptor blockade in patients addicted to opioids is abolished by intravenous clonidine.

31 March 2024

365

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Chronic mu-opioid receptor stimulation alters cardiovascular regulation in humans: differential effects on muscle sympathetic and heart rate responses to arterial hypotension.

31 March 2024

366

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Injection of alpha-MSH, but not beta-endorphin, into the PVN decreases POMC gene expression in the ARC.

31 March 2024

367

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Distribution of nociceptin-like immunoreactivity in the central nervous system of the Mongolian gerbil: an immunohistochemical study

31 March 2024

368

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Nociceptin/orphanin FQ increases ANP secretion in neonatal cardiac myocytes

31 March 2024

369

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Regulation of cyclic AMP-dependent response element-binding protein (CREB) by the nociceptin/orphanin FQ in human dopaminergic SH-SY5Y cells

31 March 2024

370

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Role of proto-oncogenes in the regulation of proenkephalin mRNA expression induced by repeated nicotine injections in rat adrenal medulla

31 March 2024

371

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effects of morphine withdrawal on micro-opioid receptor-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate autoradiography in rat brain

31 March 2024

372

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Inhibitory effects of opioids on voltage-dependent Ca(2+) channels and catecholamine secretion in cultured porcine adrenal chromaffin cells

31 March 2024

373

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Brain and body hyperthermia associated with heroin self-administration in rats.

31 March 2024

374

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Naloxone reduces levodopa-induced dyskinesias and apomorphine-induced rotations in primate models of parkinsonism

31 March 2024

375

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Disruption of temporally organized behavior by morphine

31 March 2024

376

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Differential promoter usage of mouse mu-opioid receptor gene during development

31 March 2024

377

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

cDNA microarray analysis of the differential gene expression in the neuropathic pain and electroacupuncture treatment models

31 March 2024

378

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Orphanin FQ inhibits capsaicin-induced thermal nociception in monkeys by activation of peripheral ORL1 receptors

31 March 2024

379

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Quantitative analysis of nociceptin in blood of patients with acute and chronic pain

31 March 2024

380

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Delta-opioid receptor-induced late preconditioning is mediated by cyclooxygenase-2 in conscious rabbits

31 March 2024

381

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Ethanol consumption patterns and conditioned place preference in mice lacking preproenkephalin

31 March 2024

382

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The neuropathologic effects in rats and neurometabolic effects in humans of large-dose remifentanil

31 March 2024

383

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Acupuncture analgesia in a new rat model of ankle sprain pain

31 March 2024

384

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Orphanin FQ/nociceptin but not Ro 65-6570 inhibits the expression of cocaine-induced conditioned place preference

31 March 2024

385

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Buprenorphine alleviates neuropathic pain-like behaviors in rats after spinal cord and peripheral nerve injury

31 March 2024

386

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Potentiation of the excitatory action of NMDA in ventrolateral periaqueductal gray by the mu-opioid receptor agonist, DAMGO.

31 March 2024

387

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Met-enkephalin immunoreactive neurons recruited by acute stress are innervated by axon terminals immunopositive for tyrosine hydroxylase and dopamine-alpha-hydroxylase in the anterolateral division of bed nuclei of the stria terminalis in the rat.

31 March 2024

388

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Pharmacotherapy of addictions

31 March 2024

389

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Regional differences in bioavailability of an opioid tetrapeptide in vivo in rats after administration to the respiratory tract

31 March 2024

391

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Reversal of sex differences in morphine analgesia elicited from the ventrolateral periaqueductal gray in rats by neonatal hormone manipulations

31 March 2024

392

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Relationship between NOC/oFQ, dynorphin, and COX-2 activation in impaired NMDA cerebrovasodilation after brain injury

31 March 2024

393

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Cross-tolerance between the different mu-opioid receptor agonists endomorphin-1, endomorphin-2 and morphine at the spinal level in the rat.

31 March 2024

394

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Hypoglycemia-induced suppression of luteinizing hormone (LH) secretion in intact female rhesus macaques: role of vasopressin and endogenous opioids.

31 March 2024

395

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Analysis of opioid receptor subtype antagonist effects upon mu opioid agonist-induced feeding elicited from the ventral tegmental area of rats

31 March 2024

396

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Self-administration of heroin produces alterations in the expression of inducible nitric oxide synthase

31 March 2024

397

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effects of morphine and morphine withdrawal on brainstem neurons innervating hypothalamic nuclei that control the pituitary-adrenocortical axis in rats

31 March 2024

398

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Morphine withdrawal-induced c-fos expression in the hypothalamic paraventricular nucleus is dependent on the activation of catecholaminergic neurones

31 March 2024

399

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Heritability of nociception. III. Genetic relationships among commonly used assays of nociception and hypersensitivity

31 March 2024

400

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Antinociceptive activity of a novel buprenorphine analogue.

31 March 2024

401

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Comparison of antiepileptic drugs tiagabine, lamotrigine, and gabapentin in mouse models of acute, prolonged, and chronic nociception

31 March 2024

402

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance

31 March 2024

403

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Motivational state determines the functional role of the mesolimbic dopamine system in the mediation of opiate reward processes

31 March 2024

404

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Nociceptin/orphanin FQ and related peptides reduce the increase in plasma corticosterone elicited in mice by an intracerebroventricular injection

31 March 2024

405

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Evidence for a localization of [(3)H]nociceptin binding sites on medullar primary afferent fibers

31 March 2024

406

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The effect of enzyme inhibitor and absorption site following [D-ala2, D-leu5]enkephalin oral administration in rats

31 March 2024

407

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Internalization and trafficking of opioid receptor ligands in rat cortical neurons

31 March 2024

408

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Opioid receptor polymorphisms and opioid abuse

31 March 2024

409

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Induction of antinociception and increased met-enkephalin plasma levels by cyclosporine and morphine in rats: implications of the combined use of cyclosporine and morphine and acute posttransplant neuropsychosis

31 March 2024

410

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Impulse control differences between abstinent heroin users and matched controls

31 March 2024

411

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The effect of dexamethasone upon patient-controlled analgesia-related nausea and vomiting

31 March 2024

412

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

RB101(S), a dual inhibitor of enkephalinases does not induce antinociceptive tolerance, or cross-tolerance with morphine: a c-Fos study at the spinal level.

31 March 2024

413

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Opiate-induced motor stimulation is regulated by gamma-aminobutyric acid type B receptors found in the ventral tegmental area in mice

31 March 2024

414

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Central nucleus of the amygdala and the control of tonic immobility in guinea pigs

31 March 2024

415

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Proenkephalin A gene products activate a new family of sensory neuron--specific GPCRs

31 March 2024

416

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Opioid receptor gene expression in dopamine transporter knock-out mice in adult and during development

31 March 2024

417

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Analgesic efficacy of continuous delivery of bupivacaine by an elastomeric balloon infusor after abdominal hysterectomy: a prospective randomised controlled trial

31 March 2024

418

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The orphanin receptor agonist RO 64-6198 does not induce place conditioning in rats

31 March 2024

419

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Tonic inhibitory control exerted by opioid peptides in the paraventricular nuclei of the hypothalamus on regional hemodynamic activity in rats

31 March 2024

420

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Prior experience with wheel running produces cross-tolerance to the rewarding effect of morphine

31 March 2024

421

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Oligomerization of opioid receptors: generation of novel signaling units

31 March 2024

422

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Defense of body weight depends on dietary composition and palatability in rats with diet-induced obesity

31 March 2024

423

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Naltrexone infusion inhibits the development of preference for a high-sucrose diet

31 March 2024

424

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Naloxone methiodide reverses opioid-induced respiratory depression and analgesia without withdrawal

31 March 2024

425

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Molecular basis of differences in (-)(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidiny)-cyclohexyl]benzeneacetamide-induced desensitization and phosphorylation between human and rat kappa-opioid receptors expressed in Chinese hamster ovary cells

31 March 2024

426

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Induction of the mouse kappa-opioid receptor gene by retinoic acid in P19 cells

31 March 2024

427

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Anti-nociceptive effect of neuropeptide Y in the nucleus accumbens of rats: an involvement of opioid receptors in the effect.

31 March 2024

429

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Immunosuppression induced by central action of morphine is not blocked by mifepristone (RU 486).

31 March 2024

430

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

mu-Opioid receptors and limbic responses to aversive emotional stimuli

31 March 2024

431

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The effects of morphine on chained and clocked fixed-interval schedule performance in pigeons

31 March 2024

432

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Expression and purification of a neuropeptide nocistatin using two related plant viral vectors

31 March 2024

433

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Intestinal transit of fat depends on accelerating effect of cholecystokinin and slowing effect of an opioid pathway

31 March 2024

435

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Release of beta-endorphin from adrenal gland to lower plasma glucose by the electroacupuncture at Zhongwan acupoint in rats

31 March 2024

436

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The effect of high and low frequency electroacupuncture in pain after lower abdominal surgery

31 March 2024

437

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Neurochemical properties of the prolactin releasing peptide (PrRP) receptor expressing neurons: evidence for a role of PrRP as a regulator of stress and nociception

31 March 2024

438

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Nociceptin/orphanin FQ tissue concentration in the rat brain. Effects of repeated ethanol administration at various post-treatment intervals

31 March 2024

439

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The alpha9/alpha10-containing nicotinic ACh receptor is directly modulated by opioid peptides, endomorphin-1, and dynorphin B, proposed efferent cotransmitters in the inner ear.

31 March 2024

440

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Inhibitory effect of nociceptin on somatostatin secretion of the isolated perfused rat stomach

31 March 2024

441

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Chronic agonist treatment converts antagonists into inverse agonists at delta-opioid receptors

31 March 2024

442

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms.

31 March 2024

443

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Involvement of 5-hydroxytryptamine(1A) receptors in the descending anti-nociceptive pathway from periaqueductal gray to the spinal dorsal horn in intact rats, rats with nerve injury and rats with inflammation

31 March 2024

444

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Mechanism of sorting proopiomelanocortin and proenkephalin to the regulated secretory pathway of neuroendocrine cells

31 March 2024

445

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Opioid activity in behavioral and heart rate responses of tethered pigs to acute stress

31 March 2024

446

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Kappa-opioid receptor agonist inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion and CXCR4 expression on CD4(+) lymphocytes

31 March 2024

447

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Continuous intraventricular clonidine infusion in controlled morphine withdrawal--case report

31 March 2024

448

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Increased CNS uptake and enhanced antinociception of morphine-6-glucuronide in rats after inhibition of P-glycoprotein

31 March 2024

449

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The influence of inhibition of probenecid sensitive transporters on the central nervous system (CNS) uptake and the antinociceptive activity of morphine-6-glucuronide in rats

31 March 2024

450

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine

31 March 2024

451

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Pharmacokinetic modeling to predict morphine and morphine-6-glucuronide plasma concentrations in healthy young volunteers

31 March 2024

452

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Drug interactions with patient-controlled analgesia

31 March 2024

453

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Does the A118G polymorphism at the mu-opioid receptor gene protect against morphine-6-glucuronide toxicity?

31 March 2024

454

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Functional magnetic resonance neuroimaging of drug dependence: naloxone-precipitated morphine withdrawal

31 March 2024

455

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

mu-Opioid receptors desensitize less rapidly than delta-opioid receptors due to less efficient activation of arrestin

31 March 2024

456

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Gene-gun particle with pro-opiomelanocortin cDNA produces analgesia against formalin-induced pain in rats

31 March 2024

457

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Reactivation of morphine conditioned place preference by drug priming: role of environmental cues and sensitization

31 March 2024

458

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Short-term treatment of post-traumatic stress disorder with naltrexone: an open-label preliminary study

31 March 2024

459

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs inflammatory pain

31 March 2024

460

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Nociceptin inhibits excitatory but not inhibitory transmission to substantia gelatinosa neurones of adult rat spinal cord

31 March 2024

462

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Orphanin FQ/nociceptin blocks cocaine-induced behavioral sensitization in rats

31 March 2024

463

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Sensitization does not develop to cocaine-induced potentiation of the antinociceptive effect of morphine

31 March 2024

464

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Anti-mu-opioid-receptor IgG antibodies are commonly present in serum from healthy blood donors: evidence for a role in apoptotic immune cell death

31 March 2024

465

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Opioid control of inflammatory pain regulated by intercellular adhesion molecule-1

31 March 2024

466

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

A randomized, double-blinded comparison of thoracic epidural ropivacaine, ropivacaine/fentanyl, or bupivacaine/fentanyl for postthoracotomy analgesia

31 March 2024

467

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The effects of pituitary adenylate cyclase-activating polypeptide on acute and chronic morphine actions in mice.

31 March 2024

468

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Inhibition of oxytocin release during repeated milking in unfamiliar surroundings: the importance of opioids and adrenal cortex sensitivity.

31 March 2024

469

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effects of diltiazem and MK-801 on morphine analgesia and pharmacokinetics in mice

31 March 2024

470

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Naloxone-precipitated morphine withdrawal elicits increases in c-fos mRNA expression in restricted regions of the infant rat brain

31 March 2024

471

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Morphine regulates gene expression of alpha- and beta-chemokines and their receptors on astroglial cells via the opioid mu receptor

31 March 2024

472

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Amniotic fluid beta-endorphin: a prognostic marker for gastroschisis?

31 March 2024

473

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effect of intracerebroventricular injection of GABA receptor agents on morphine-induced antinociception in the formalin test

31 March 2024

474

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Rat ventral midbrain dopamine neurons express the orphanin FQ/nociceptin receptor ORL-1.

31 March 2024

475

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Morphine responsiveness, efficacy and tolerability in patients with chronic non-tumor associated pain - results of a double-blind placebo-controlled trial (MONTAS).

31 March 2024

476

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Cannabinoid addiction: behavioral models and neural correlates.

31 March 2024

477

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Morphine-induced macrophage apoptosis modulates migration of macrophages: use of in vitro model of urinary tract infection

31 March 2024

478

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Orphanin FQ/nociceptin-mediated desensitization of opioid receptor-like 1 receptor and mu opioid receptors involves protein kinase C: a molecular mechanism for heterologous cross-talk

31 March 2024

479

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The role of mu-opioid receptors in inflammatory hyperalgesia and alpha 2-adrenoceptor-mediated antihyperalgesia.

31 March 2024

480

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Morphine 6 glucuronide stimulates nitric oxide release in mussel neural tissues: evidence for a morphine 6 glucuronide opiate receptor subtype

31 March 2024

481

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Chronic morphine induces downregulation of spinal glutamate transporters: implications in morphine tolerance and abnormal pain sensitivity.

31 March 2024

482

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Neuronal apoptosis associated with morphine tolerance: evidence for an opioid-induced neurotoxic mechanism.

31 March 2024

483

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Impaired preprodynorphin, but not preproenkephalin, mRNA induction in the striatum of mGluR1 mutant mice in response to acute administration of the full dopamine D(1) agonist SKF-82958.

31 March 2024

484

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Rostral ventromedial medulla neurons that project to the spinal cord express multiple opioid receptor phenotypes.

31 March 2024

485

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Hyperalgesia and blunted morphine analgesia in G protein-gated potassium channel subunit knockout mice

31 March 2024

486

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Nociceptin/orphanin FQ receptors modulate glutamate extracellular levels in the substantia nigra pars reticulata. A microdialysis study in the awake freely moving rat.

31 March 2024

487

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Agonist, antagonist, and inverse agonist characteristics of TIPP (H-Tyr-Tic-Phe-Phe-OH), a selective delta-opioid receptor ligand

31 March 2024

488

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Differential involvement of mu-opioid receptors in the rostral versus caudal nucleus accumbens in the reinforcing effects of heroin in rats: evidence from focal injections of beta-funaltrexamine

31 March 2024

489

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The glycine/NMDA receptor antagonist (+)-HA966 enhances the peripheral effect of morphine in neuropathic rats

31 March 2024

490

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Agonists activate Gi1 alpha or Gi2 alpha fused to the human mu opioid receptor differently

31 March 2024

491

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

A combination of gabapentin and morphine mediates enhanced inhibitory effects on dorsal horn neuronal responses in a rat model of neuropathy

31 March 2024

492

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Mild stress sensitizes the brain's response to morphine

31 March 2024

493

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Anticonvulsant effects of four neuropeptides in the rat hippocampus during self-sustaining status epilepticus

31 March 2024

494

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Knockout of ERK1 MAP kinase enhances synaptic plasticity in the striatum and facilitates striatal-mediated learning and memory

31 March 2024

495

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Blockade of nigral and pallidal opioid receptors suppresses vacuous chewing movements in a rodent model of tardive dyskinesia

31 March 2024

496

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Comparison between repeat bolus intrathecal morphine and an epidurally delivered bupivacaine and fentanyl combination in the management of post-thoracotomy pain with or without cyclooxygenase inhibition

31 March 2024

497

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effects of [(pF)Phe(4)]nociceptin/orphanin FQ-(1-13)NH(2) on GTPgamma(35)S binding and cAMP formation in Chinese hamster ovary cells expressing the human nociceptin/orphanin FQ receptor.

31 March 2024

498

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Microinjection of morphine into various amygdaloid nuclei differentially affects nociceptive responsiveness and RVM neuronal activity

31 March 2024

499

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

A comparison of antagonist-precipitated withdrawal under anesthesia to standard inpatient withdrawal as a precursor to maintenance naltrexone treatment in heroin users: outcomes at 6 and 12 months

31 March 2024

500

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Exposure to the opioid antagonist naltrexone throughout gestation alters postnatal heart development

31 March 2024

501

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Chronic exposure to the opioid growth factor, [Met5]-enkephalin, during pregnancy: maternal and preweaning effects

31 March 2024

502

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Antitussive effect of nociceptin/orphanin FQ in experimental cough models

31 March 2024

503

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The discrimination of drug mixtures using a four-choice procedure in pigeons

31 March 2024

504

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal

31 March 2024

505

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

A rat model of bone cancer pain

31 March 2024

506

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Immunomodulation by biphalin, dimeric synthetic opioid peptide, and its analog

31 March 2024

507

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Sigma1 receptor modulation of opioid analgesia in the mouse

31 March 2024

508

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Pharmacokinetic modelling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphine

31 March 2024

509

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Antioscillatory effects of nociceptin/orphanin FQ in synaptic networks of the rat thalamus

31 March 2024

510

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Fatal versus non-fatal heroin "overdose": blood morphine concentrations with fatal outcome in comparison to those of intoxicated drivers

31 March 2024

511

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington's disease knock-in mice

31 March 2024

512

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Unilateral hot plate test: a simple and sensitive method for detecting central and peripheral hyperalgesia in mice

31 March 2024

513

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Longitudinal follow-up of TTS-fentanyl use in patients with cancer-related pain: results of a compassionate-use study with special focus on elderly patients

31 March 2024

514

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Oestrogen modulates cholecystokinin: opioid interactions in the nervous system.

31 March 2024

515

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Rotational behaviour in AA and ANA rats after repeated administration of morphine and cocaine

31 March 2024

516

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effect of naloxone-precipitated morphine withdrawal on CRH and vasopressin mRNA expression in the rat hypothalamic paraventricular nucleus

31 March 2024

517

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Apposition of enkephalinergic axons with cGnRH I-containing perikarya in turkey hen brain

31 March 2024

518

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Descending control of pain

31 March 2024

519

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Excitotoxic lesions of the pedunculopontine differentially mediate morphine- and d-amphetamine-evoked striatal dopamine efflux and behaviors

31 March 2024

520

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Spontaneous recovery of tolerance to the analgesic effect of morphine

31 March 2024

521

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

C1 adrenergic neurons are contacted by presynaptic profiles containing DELTA-opioid receptor immunoreactivity

31 March 2024

522

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Puerperal blockade of cholecystokinin (CCK1) receptors disrupts maternal behavior in lactating rats

31 March 2024

523

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Mu and kappa opioid agonists modulate ventral tegmental area input to the ventral pallidum

31 March 2024

524

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Activation of mu-opioid receptors in rat ventrolateral medulla selectively blocks baroreceptor reflexes while activation of delta opioid receptors blocks somato-sympathetic reflexes

31 March 2024

525

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Antagonistic property of buprenorphine for putative epsilon-opioid receptor-mediated G-protein activation by beta-endorphin in pons/medulla of the mu-opioid receptor knockout mouse.

31 March 2024

526

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Loss of mu-opioid receptor-mediated G-protein activation in the pons/medulla of mice lacking the exons 2 and 3 of mu-opioid receptor gene

31 March 2024

527

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Enhanced antinociception by intrathecally-administered morphine in histamine H1 receptor gene knockout mice.

31 March 2024

528

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Stress-specific opioid modulation of haemodynamic counter-regulation

31 March 2024

529

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Social suppression in nonreproductive female Damaraland mole-rats, Cryptomys damarensis: no apparent role for endogenous opioid peptides

31 March 2024

530

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Systemic morphine selectively depresses a thalamic link of widespread nociceptive inputs in the rat.

31 March 2024

531

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Morphine-3beta-D-glucuronide suppresses inhibitory synaptic transmission in rat substantia gelatinosa

31 March 2024

532

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effects of a newly synthesized kappa-opioid receptor agonist, TRK-820, on the discriminative stimulus and rewarding effects of cocaine in rats

31 March 2024

533

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Intrinsic GABA neurons inhibit proenkephalin gene expression in slice cultures of rat neostriatum

31 March 2024

534

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Central neuropeptide systems and respiratory control during development

31 March 2024

535

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Persistence and drug-induced reinstatement of a morphine-induced conditioned place preference.

31 March 2024

536

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Involvement of central K(ATP) channels in the gastric antisecretory action of alpha2-adrenoceptor agonists and beta-endorphin in rats

31 March 2024

537

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Increases in the release and metabolism of serotonin in nucleus parafascicularis thalami following systemically administered morphine in the rat.

31 March 2024

538

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Characterization of nociceptin/orphanin FQ-induced pain responses by the novel receptor antagonist N-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl) benzamide monohydrochloride

31 March 2024

539

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effect of the addition of ketamine to morphine in patient-controlled analgesia

31 March 2024

540

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Heroin-induced locomotion and mesolimbic dopamine release is unchanged in mice lacking the ORL.1 receptor gene

31 March 2024

541

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Contribution of morphine-6-glucuronide to antinociception following intravenous administration of morphine to healthy volunteers.

31 March 2024

542

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Noradrenaline release in rat locus coeruleus is regulated by both opioid and alpha(2) -adrenoceptors

31 March 2024

543

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The role of contextual cues on counterirritation in the development process of analgesic tolerance to morphine

31 March 2024

544

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

An analysis of the effects of contextual cues on the development of morphine tolerance in rats

31 March 2024

545

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The effect of gamma-aminobutyric acid (GABA) receptor drugs on morphine-induced spastic paraparesis after a noninjurious interval of spinal cord ischemia in rats

31 March 2024

546

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Sensitization to cocaine after a single intra-cerebral injection of orphanin FQ/nociceptin

31 March 2024

547

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Site and mechanism of action of dynorphin A-(1-13) and N-methyl-D-aspartate on ACTH release in fetal sheep

31 March 2024

548

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Possible involvement of mu1-opioid receptors in the fentanyl- or morphine-induced antinociception at supraspinal and spinal sites

31 March 2024

549

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effect of repeated administration of morphine on the activity of extracellular signal regulated kinase in the mouse brain

31 March 2024

550

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Influence of a deletion of protein kinase C gamma isoform in the G-protein activation mediated through opioid receptor-like-1 and mu-opioid receptors in the mouse pons/medulla

31 March 2024

551

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Implications of phosphoinositide 3-kinase in the mu- and delta-opioid receptor-mediated supraspinal antinociception in the mouse

31 March 2024

552

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effect of synthetic beta-endorphin-like peptide immunorphin on human T lymphocytes

31 March 2024

553

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Raloxifene treatment increases plasma levels of beta-endorphin in postmenopausal women: a randomized, placebo-controlled study

31 March 2024

554

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Delta opioid antagonist effects of buprenorphine in rhesus monkeys

31 March 2024

555

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effects of gonadal steroid hormone treatments on opioid antinociception in ovariectomized rhesus monkeys

31 March 2024

556

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effects of mu-opioid agonists on cocaine- and food-maintained responding and cocaine discrimination in rhesus monkeys: role of mu-agonist efficacy

31 March 2024

557

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys

31 March 2024

558

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Role of benzodiazepine-GABAA receptor complex in attenuation of U-50,488H-induced analgesia and inhibition of tolerance to its analgesia by ginseng total saponin in mice

31 March 2024

559

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Endocrine effects of centrally injected nociceptin in the rat.

31 March 2024

560

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The ORL1 receptor: molecular pharmacology and signalling mechanisms

31 March 2024

561

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Heroin discriminative stimulus effects of methadone, LAAM and other isomers of acetylmethadol in rats

31 March 2024

562

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Characterization of mu, kappa, and delta opioid binding in amphibian whole brain tissue homogenates

31 March 2024

563

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect.

31 March 2024

564

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Orphanin FQ-induced hyperphagia is mediated by corticosterone and central glucocorticoid receptors

31 March 2024

565

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Nociceptin/orphanin FQ inhibits glutamate release from rat cerebellar and brain stem slices.

31 March 2024

566

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Chronic morphine treatment modulates the extracellular levels of endogenous enkephalins in rat brain structures involved in opiate dependence: a microdialysis study.

31 March 2024

567

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The role of opioid systems on orthodontic tooth movement in cholestatic rats

31 March 2024

568

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effect of precipitated morphine withdrawal on post-translational processing of prothyrotropin releasing hormone (proTRH) in the ventrolateral column of the midbrain periaqueductal gray

31 March 2024

569

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Genetic dissociation of opiate tolerance and physical dependence in delta-opioid receptor-1 and preproenkephalin knock-out mice.

31 March 2024

570

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effect of dietary fiber on morphine-induced constipation in rats

31 March 2024

571

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Nociceptin/orphanin FQ and opioid receptor-like receptor mRNA expression in dopamine systems

31 March 2024

572

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Spinal and peripheral mu opioids and the development of secondary tactile allodynia after thermal injury

31 March 2024

573

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Blockade of the antinociceptive effect of spinally administered kyotorphin by naltrindole in mice

31 March 2024

574

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The spinal antinociceptive effect of kyotorphin in mice: involvement of the descending noradrenergic and serotonergic systems

31 March 2024

575

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Synthesis and structure-activity relationships of an orally available and long-acting analgesic peptide, N(alpha)-amidino-Tyr-D-Arg-Phe-MebetaAla-OH (ADAMB).

31 March 2024

576

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effects of dynorphin on rat entopeduncular nucleus neurons in vitro

31 March 2024

577

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Dihydroetorphine: A Potent Analgesic: Pharmacology, Toxicology, Pharmacokinetics, and Clinical Effects

31 March 2024

578

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Endomorphins and related opioid peptides

31 March 2024

579

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Pharmacological properties of nociceptin/orphanin FQ-induced stimulation and inhibition of cyclic AMP formation in distinct layers of rat olfactory bulb

31 March 2024

580

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The antinociceptive effect of tramadol in the formalin test is mediated by the serotonergic component

31 March 2024

581

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Enkephalinergic control of the secretory activity of neurons producing stereoisomers of crustacean hyperglycemic hormone in the eyestalk of the crayfish Orconectes limosus.

31 March 2024

582

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effect of nociceptin/orphanin FQ on food intake in rats that differ in diet preference.

31 March 2024

583

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Evaluation of opioid peptide and muscarinic receptors in human epileptogenic neocortex: an autoradiography study

31 March 2024

584

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Stimulation of peripheral nociceptor endings by low dose morphine and its signaling mechanism

31 March 2024

585

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Determinants of ligand selectivity at the kappa-receptor based on the structure of the orphanin FQ receptor

31 March 2024

586

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effects of naloxone and post-tetanic stimulation on isolated guinea-pig ileum followed by long exposure to morphine and bestatin

31 March 2024

587

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Suppression of the morphine-induced rewarding effect and G-protein activation in the lower midbrain following nerve injury in the mouse: involvement of G-protein-coupled receptor kinase 2.

31 March 2024

588

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The decline in serum choline concentration in humans during and after surgery is associated with the elevation of cortisol, adrenocorticotropic hormone, prolactin and beta-endorphin concentrations

31 March 2024

589

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Neutrophils and the calcium-binding protein MRP-14 mediate carrageenan-induced antinociception in mice

31 March 2024

590

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Influence of mianserin on the antinociceptive effect of morphine, metamizol and indomethacin in mice

31 March 2024

591

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Identification and characterization of a novel promoter of the mouse mu opioid receptor gene (Oprm) that generates eight splice variants

31 March 2024

592

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Dimerization of morphine and orphanin FQ/nociceptin receptors: generation of a novel opioid receptor subtype

31 March 2024

593

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Activation of delta-opioid receptors excites spinally projecting locus coeruleus neurons through inhibition of GABAergic inputs

31 March 2024

594

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Peripheral blood mononuclear cell beta-endorphin concentration is decreased in chronic fatigue syndrome and fibromyalgia but not in depression: preliminary report.

31 March 2024

595

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Selective blockade of drug-induced place preference conditioning by ACPC, a functional NDMA-receptor antagonist.

31 March 2024

596

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

A novel signaling pathway of nitric oxide on transcriptional regulation of mouse kappa opioid receptor gene.

31 March 2024

597

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Ibogaine interferes with motivational and somatic effects of naloxone-precipitated withdrawal from acutely administered morphine

31 March 2024

598

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Amphetamine and morphine produce a conditioned taste and place preference in the house musk shrew (Suncus murinus).

31 March 2024

599

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The aversive properties of acute morphine dependence persist 48 h after a single exposure to morphine: evaluation by taste and place conditioning

31 March 2024

600

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Attenuation of heat shock-induced cardioprotection by treatment with the opiate receptor antagonist naloxone

31 March 2024

601

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Delta opioid agonists and volatile anesthetics facilitate cardioprotection via potentiation of K(ATP) channel opening

31 March 2024

602

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Cardioprotection at a distance: mesenteric artery occlusion protects the myocardium via an opioid sensitive mechanism

31 March 2024

603

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Antagonist-induced micro-opioid receptor up-regulation decreases G-protein receptor kinase-2 and dynamin-2 abundance in mouse spinal cord

31 March 2024

604

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Opioid agonists differentially regulate mu-opioid receptors and trafficking proteins in vivo

31 March 2024

605

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Pilot study of nasal morphine-chitosan for the relief of breakthrough pain in patients with cancer.

31 March 2024

606

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The orofacial capsaicin test in rats: effects of different capsaicin concentrations and morphine

31 March 2024

607

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

AMPA receptor antagonist LY293558 reverses preproenkephalin mRNA overexpression in the striatum of 6-OHDA-lesioned-rats treated with L-dopa

31 March 2024

608

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Neuropathy reduces viscero-somatic inhibition via segmental mechanisms in rats

31 March 2024

609

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Ligands act as pharmacological chaperones and increase the efficiency of delta opioid receptor maturation

31 March 2024

610

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Placebo and opioid analgesia-- imaging a shared neuronal network

31 March 2024

611

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Expression of orphanin FQ/nociceptin and its receptor in rat peripheral ganglia and spinal cord

31 March 2024

612

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Opioid addiction changes cerebral blood flow symmetry

31 March 2024

613

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effect of opioid and cannabinoid receptor antagonism on orphanin FQ-induced hyperphagia in rats

31 March 2024

614

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effects of melanocortin receptor ligands on ethanol intake and opioid peptide levels in alcohol-preferring AA rats

31 March 2024

615

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effects of maternal separation on brain nociceptin/orphanin FQ peptide levels in male Wistar rats

31 March 2024

616

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Persistent secondary hyperalgesia after gastrocnemius incision in the rat.

31 March 2024

617

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Deletion of CCK2 receptor in mice results in an upregulation of the endogenous opioid system.

31 March 2024

618

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Chemical coding of neurons expressing delta- and kappa-opioid receptor and type I vanilloid receptor immunoreactivities in the porcine ileum

31 March 2024

619

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Morphine conditioned reward is inhibited by MPEP, the mGluR5 antagonist

31 March 2024

620

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Central serotonin4 receptors selectively regulate the impulse-dependent exocytosis of dopamine in the rat striatum: in vivo studies with morphine, amphetamine and cocaine

31 March 2024

621

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum.

31 March 2024

622

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Chronic pain and medullary descending facilitation

31 March 2024

623

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

In vivo and in vitro potency studies of 6beta-naltrexol, the major human metabolite of naltrexone

31 March 2024

624

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats

31 March 2024

625

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Knockdown of spinal opioid receptors by antisense targeting beta-arrestin reduces morphine tolerance and allodynia in rat.

31 March 2024

626

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Hippocampal long-term potentiation is reduced by chronic opiate treatment and can be restored by re-exposure to opiates.

31 March 2024

628

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The diverse molecular mechanisms responsible for the actions of opioids on the cardiovascular system

31 March 2024

629

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Dietary peptides induce satiety via cholecystokinin-A and peripheral opioid receptors in rats

31 March 2024

630

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Endomorphins inhibit contractile responses of rat thoracic aorta rings induced by phenylephrine and angiotensin II in vitro

31 March 2024

631

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Distribution of leucine-enkephalin in bone and joint tissues

31 March 2024

632

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Dissociation of pharmacological pro- and anti-opioid effects by neuropeptide FF analogs

31 March 2024

633

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Increases in striatal preproenkephalin gene expression are associated with nigrostriatal damage but not L-DOPA-induced dyskinesias in the squirrel monkey

31 March 2024

634

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Differential effects of mu-opioid receptor ligands on Ca(2+) signaling

31 March 2024

635

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Kappa opioid receptor is expressed by somatostatin- and neuropeptide Y-containing interneurons in the rat hippocampus

31 March 2024

636

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Nociceptin and dynorphin A(1-17) produce antianalgesia through independent systems in mice

31 March 2024

637

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Methadone and heroin antinociception: predominant delta-opioid-receptor responses in methadone-tolerant mice

31 March 2024

638

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats.

31 March 2024

639

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Abrupt or precipitated withdrawal from morphine induces immunosuppression

31 March 2024

640

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial

31 March 2024

641

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Modulation of cholestasis-induced antinociception by CCK receptor agonists and antagonists

31 March 2024

643

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effects of opioid antagonists on unconditioned and conditioned hyperactivity to morphine

31 March 2024

644

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Nociceptin receptor antagonists display antidepressant-like properties in the mouse forced swimming test

31 March 2024

645

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Increased splenocyte proliferative response and cytokine production in beta-endorphin-deficient mice

31 March 2024

646

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The orphanin FQ/nociceptin knockout mouse: a behavioral model for stress responses

31 March 2024

647

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Synthesis and biological activities of cyclic lanthionine enkephalin analogues: delta-opioid receptor selective ligands

31 March 2024

648

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Involvement of dopamine D2 receptors of the central amygdala on the acquisition and expression of morphine-induced place preference in rat.

31 March 2024

649

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

[Dmt(1)]DALDA is highly selective and potent at mu opioid receptors, but is not cross-tolerant with systemic morphine

31 March 2024

650

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Morphine tolerance in spinal cord is due to interaction between mu- and delta-receptors

31 March 2024

651

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Conditioned place preference to morphine in cannabinoid CB1 receptor knockout mice

31 March 2024

652

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Lack of self-administration and behavioural sensitisation to morphine, but not cocaine, in mice lacking NK1 receptors

31 March 2024

653

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Conditioning tastant and the acquisition of conditioned taste avoidance to drugs of abuse in DBA/2J mice

31 March 2024

654

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Inhibitory effect of neurogenic and immune stressors on testosterone secretion in rats

31 March 2024

655

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Pharmacological characterisation of [(pX)Phe 4 ]nociceptin(1-13)NH 2 analogues

31 March 2024

656

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

[Arg(14),Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies

31 March 2024

657

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Metabotropic glutamate receptor 2/3-dependent long-term depression in the nucleus accumbens is blocked in morphine withdrawn mice.

31 March 2024

658

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Oxytocin mediates stress-induced analgesia in adult mice

31 March 2024

659

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Widespread but regionally specific effects of experimenter- versus self-administered morphine on dendritic spines in the nucleus accumbens, hippocampus, and neocortex of adult rats

31 March 2024

660

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Pro-nociceptin/orphanin FQ and NOP receptor mRNA levels in the forebrain of food deprived rats.

31 March 2024

661

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Environment associated with morphine and experience of aggression modulate behaviors of postdependent mice

31 March 2024

662

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Memantine does not block antiaggressive effects of morphine in mice

31 March 2024

663

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Evidence for changes in brain enkephalin contents associated to male rat sexual activity

31 March 2024

664

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Antinociceptive, behavioural and neuroendocrine effects of CP 55,940 in young rats

31 March 2024

666

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Comparison of the ORL1 receptor-mediated inhibition of noradrenaline release in human and rat neocortical slices

31 March 2024

667

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Modulation of proorphaninFQ/N gene expression by morphine in the rat mesocorticolimbic system.

31 March 2024

668

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Gyrus cinguli transection abolishes delta-opioid receptor-induced gastroprotection and alters alpha 2 adrenoceptor activity in the lower brainstem in rats

31 March 2024

669

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Characterization of rat prepro-orphanin FQ/nociceptin((154-181)): nociceptive processing in supraspinal sites

31 March 2024

670

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Rapid quantification of the delta-opioid receptor selective enkephalin DPDPE in canine cerebrospinal fluid by liquid chromatography--mass spectrometry

31 March 2024

671

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist

31 March 2024

672

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The neurosteroid allopregnanolone increases dopamine release and dopaminergic response to morphine in the rat nucleus accumbens

31 March 2024

673

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Changes in extracellular dopamine induced by morphine and cocaine: crucial control by D2 receptors

31 March 2024

674

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Nociceptin, OP4 receptor ligand in different models of experimental epilepsy.

31 March 2024

675

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effect of agmatine on locus coeruleus neuron activity: possible involvement of nitric oxide

31 March 2024

676

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Naltrexone attenuates plasma nitric oxide release following acute heat stress

31 March 2024

678

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The effect of nitric oxide synthase blockade on responses to morphine in rat aortic rings

31 March 2024

679

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

CJ-15,208, a novel kappa opioid receptor antagonist from a fungus, Ctenomyces serratus ATCC15502.

31 March 2024

680

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Degradation of nociceptin (orphanin FQ) by mouse spinal cord synaptic membranes is triggered by endopeptidase-24.11: an in vitro and in vivo study

31 March 2024

681

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Differential antinociceptive effects induced by intrathecally-administered endomorphin-1 and endomorphin-2 in mice

31 March 2024

682

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Differential antagonism of endomorphin-1 and endomorphin-2 supraspinal antinociception by naloxonazine and 3-methylnaltrexone

31 March 2024

683

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Intrathecal high-dose morphine induces spinally-mediated behavioral responses through NMDA receptors

31 March 2024

684

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Starting intravenous morphine in the postanesthesia care unit yielded better postoperative analgesia

31 March 2024

685

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Consequences of monosodium glutamate or goldthioglucose arcuate nucleus lesions on ethanol-induced locomotion.

31 March 2024

686

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Pharmacology of opioid inhibition to noxious uterine cervical distension

31 March 2024

687

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effect of kappa opioid agonists on visceral nociception induced by uterine cervical distension in rats

31 March 2024

688

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Responses to microinjections of endomorphin and nociceptin into the medullary cardiovascular areas

31 March 2024

689

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Green fluorescent protein as a reporter of human mu-opioid receptor overexpression and localization in the methylotrophic yeast Pichia pastoris

31 March 2024

690

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The interaction of morphine and gamma-aminobutyric acid (GABA)ergic systems in anxiolytic behavior: using mu-opioid receptor knockout mice

31 March 2024

691

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Morphine analgesia suppresses tumor growth and metastasis in a mouse model of cancer pain produced by orthotopic tumor inoculation

31 March 2024

692

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Supersensitivity of 5-HT1A autoreceptors and alpha2-adrenoceptors regulating monoamine synthesis in the brain of morphine-dependent rats

31 March 2024

693

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Endogenous opioids in dopaminergic cell body regions modulate amphetamine-induced increases in extracellular dopamine levels in the terminal regions

31 March 2024

694

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Evidence for the involvement of glutamatergic receptors in the antinociception caused in mice by the sesquiterpene drimanial

31 March 2024

695

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

A functional polymorphism within the mu-opioid receptor gene and risk for abuse of alcohol and other substances

31 March 2024

696

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Itch--mediators and mechanisms

31 March 2024

697

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

mu/delta Cooperativity and opposing kappa-opioid effects in nucleus accumbens-mediated antinociception in the rat.

31 March 2024

698

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Altered nucleus accumbens circuitry mediates pain-induced antinociception in morphine-tolerant rats.

31 March 2024

699

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Atypical on-, off- and neutral cells in the rostral ventromedial medulla oblongata in rat.

31 March 2024

700

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Venlafaxine and mirtazapine: different mechanisms of antidepressant action, common opioid-mediated antinociceptive effects--a possible opioid involvement in severe depression?

31 March 2024

701

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The antinociceptive effect of mirtazapine in mice is mediated through serotonergic, noradrenergic and opioid mechanisms

31 March 2024

702

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Conditioned Fos expression following morphine-paired contextual cue exposure is environment specific

31 March 2024

703

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

GABA(A) and mu-opioid receptor binding in the globus pallidus and endopeduncular nucleus of animals symptomatic for and recovered from experimental Parkinsonism

31 March 2024

704

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

GABA-opioid interactions in the globus pallidus: [D-Ala2]-Met-enkephalinamide attenuates potassium-evoked GABA release after nigrostriatal lesion

31 March 2024

705

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Opioid receptor types selectively cointernalize with G protein-coupled receptor kinases 2 and 3.

31 March 2024

706

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Voluntary self-administration of both morphine and cocaine by rats

31 March 2024

707

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Synthesis and biological evaluation of 14-alkoxymorphinans. 17. Highly delta opioid receptor selective 14-alkoxy-substituted indolo- and benzofuromorphinans.

31 March 2024

708

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Actions of intrathecal omega-conotoxins CVID, GVIA, MVIIA, and morphine in acute and neuropathic pain in the rat.

31 March 2024

709

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effects of DA D1 and D2 antagonists on the sensitisation to the motor effects of morphine in mice

31 March 2024

710

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effect of naloxone on perceived exertion and exercise capacity during maximal cycle ergometry

31 March 2024

711

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Involvement of mu- and kappa-, but not delta-, opioid receptors in the peristaltic motor depression caused by endogenous and exogenous opioids in the guinea-pig intestine.

31 March 2024

712

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Attenuated "cross talk" between kappa-opioid receptors and beta-adrenoceptors in the heart of chronically hypoxic rats

31 March 2024

713

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Comparison of the peripheral and central effects of the opioid agonists loperamide and morphine in the formalin test in rats

31 March 2024

715

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Attenuation of morphine tolerance after antisense oligonucleotide knock-down of spinal mGluR1.

31 March 2024

716

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Regional and cellular mapping of cAMP response element-mediated transcription during naltrexone-precipitated morphine withdrawal.

31 March 2024

717

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Presynaptic modulation of synaptic transmission by opioid receptor in rat subthalamic nucleus in vitro

31 March 2024

718

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Morphine-potentiated agonist-induced platelet aggregation through alpha2-adrenoceptors in human platelets

31 March 2024

720

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Sequence variations in the mu-opioid receptor gene (OPRM1) associated with human addiction to heroin

31 March 2024

721

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Ventral tegmental lesions reduce overconsumption of normally preferred taste fluid in rats

31 March 2024

722

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

COX-2-derived prostacyclin mediates opioid-induced late phase of preconditioning in isolated rat hearts

31 March 2024

723

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The role of nicotinic receptor beta-2 subunits in nicotine discrimination and conditioned taste aversion

31 March 2024

724

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Role of delta-opioid receptor agonists on infarct size reduction in swine

31 March 2024

725

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Dynorphin A(1-17)-induced feeding: pharmacological characterization using selective opioid antagonists and antisense probes in rats

31 March 2024

726

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Pharmacological characterization of beta-endorphin- and dynorphin A(1-17)-induced feeding using G-protein alpha-subunit antisense probes in rats

31 March 2024

727

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effect of ethanol self-administration on mu- and delta-opioid receptor-mediated G-protein activity

31 March 2024

728

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis

31 March 2024

729

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Role of p38 mitogen-activated protein kinase phosphorylation and Fas-Fas ligand interaction in morphine-induced macrophage apoptosis.

31 March 2024

730

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Intraventricular insulin decreases kappa opioid-mediated sucrose intake in rats

31 March 2024

731

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Mu-opioid receptors in seizure-controlling brain structures are altered by prenatal morphine exposure and by male and female gonadal steroids in adult rats.

31 March 2024

732

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Impact of maternal morphine and saline injections on behavioral responses to a cold water stressor in adult male and female progeny.

31 March 2024

733

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Gonadal hormone-induced changes in adult male and female rats exposed to early postnatal handling are not altered by prenatal morphine exposure

31 March 2024

734

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists

31 March 2024

735

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Prolonged reversal of morphine tolerance with no reversal of dependence by protein kinase C inhibitors

31 March 2024

736

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Dopamine D2L receptor knockout mice display deficits in positive and negative reinforcing properties of morphine and in avoidance learning

31 March 2024

737

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The effects of developmental cadmium exposure on morphine sensitization and challenge with selective D(1) and D(2) antagonists

31 March 2024

738

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Diet-induced obesity increases mu opioid receptor binding in specific regions of the rat brain

31 March 2024

739

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Classical conditioning in the rat fetus: involvement of mu and kappa opioid systems in the conditioned response

31 March 2024

740

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Classical conditioning in the rat fetus: temporal characteristics and behavioral correlates of the conditioned response

31 March 2024

741

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Regulation by endogenous opioids of suckling-induced prolactin secretion in pregnant and lactating rats: role of ovarian steroids

31 March 2024

742

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Brain regional mu-opioid receptor function in rat lines selected for differences in alcohol preference

31 March 2024

743

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Intraadministration associations: conditional hyperalgesia elicited by morphine onset cues

31 March 2024

744

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Seasonal short-term effects of naltrexone on LH secretion in male carp (Cyprinus carpio L.).

31 March 2024

745

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Key role for enkephalinergic tone in cortico-striatal-thalamic function

31 March 2024

746

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

A review of mechanisms of response to pain therapy: why voodoo works

31 March 2024

747

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effect of sodium deprivation on morphine-and lithium-induced conditioned salt avoidance and taste reactivity

31 March 2024

749

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Agonist-induced internalization and desensitization of the human nociceptin receptor expressed in CHO cells

31 March 2024

750

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Alteration in endogenous opioid systems due to chronic inflammatory pain conditions

31 March 2024

751

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

MOR-1-immunoreactive neurons in the dorsal horn of the rat spinal cord: evidence for nonsynaptic innervation by substance P-containing primary afferents and for selective activation by noxious thermal stimuli

31 March 2024

752

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

In vivo microdialysis and conditioned place preference studies in rats are consistent with abuse potential of tramadol

31 March 2024

753

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Modulation of melanocortin-induced changes in spinal nociception by mu-opioid receptor agonist and antagonist in neuropathic rats

31 March 2024

754

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Interactions between opioid and chemokine receptors: heterologous desensitization

31 March 2024

755

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Comparison of ropivacaine-fentanyl patient-controlled epidural analgesia with morphine intravenous patient-controlled analgesia for perioperative analgesia and recovery after open colon surgery

31 March 2024

758

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Thermal control of mother-young contact revisited: hyperthermic rats nurse normally

31 March 2024

759

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Delta opioid discrimination learning in the rat: assessment with the selective delta agonist SNC80.

31 March 2024

760

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Drug trace discrimination with nicotine and morphine in rats

31 March 2024

761

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Loss of antinociceptive efficacy in rat pups infused with morphine from osmotic minipumps

31 March 2024

762

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Endomorphins 1 and 2 reduce relaxant non-adrenergic, non-cholinergic neurotransmission in rat gastric fundus

31 March 2024

763

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effects of endomorphin-1 and -2 on mu-opioid receptors in myenteric neurons and in the peristaltic reflex in rat small intestine

31 March 2024

764

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Blockade of hydromorphone effects by buprenorphine/naloxone and buprenorphine

31 March 2024

765

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Menstrual cycle, beta-endorphins, and pain sensitivity in premenstrual dysphoric disorder

31 March 2024

766

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Sodium channel blocking actions of the kappa-opioid receptor agonist U50,488 contribute to its visceral antinociceptive effects

31 March 2024

767

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effects of acute and chronic caffeine intake on intravenous self-administration of morphine in two rat strains.

31 March 2024

768

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Nerve injury-induced changes in opioid modulation of wide dynamic range dorsal column nuclei neurones

31 March 2024

769

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Methadone induces CCR5 and promotes AIDS virus infection

31 March 2024

770

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Interactions of opioid and chemokine receptors: oligomerization of mu, kappa, and delta with CCR5 on immune cells

31 March 2024

771

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Kappa-Opioid and NMDA glutamate receptors are differentially targeted within rat medial prefrontal cortex

31 March 2024

772

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain

31 March 2024

773

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Inhibition of tonic spinal glutamatergic activity induces antinociception in the rat.

31 March 2024

775

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of an acyloxyalkoxy-based cyclic prodrug of the opioid peptide DADLE.

31 March 2024

776

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of the coumarinic acid-based cyclic prodrug of the opioid peptide DADLE.

31 March 2024

777

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism

31 March 2024

778

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system

31 March 2024

779

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Endomorphins suppress nociception-induced c-Fos and Zif/268 expression in the rat spinal dorsal horn

31 March 2024

780

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Alterations in striatal neuropeptide mRNA produced by repeated administration of L-DOPA, ropinirole or bromocriptine correlate with dyskinesia induction in MPTP-treated common marmosets.

31 March 2024

782

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Influence of gonadectomy on the antinociceptive effects of opioids in male and female rats

31 March 2024

783

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Orphanin FQ/nociceptin blocks chronic morphine-induced tyrosine hydroxylase upregulation

31 March 2024

784

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Delta opioid inhibition of light-induced phase advances in hamster circadian activity rhythms

31 March 2024

785

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Antipruritic activity of the kappa-opioid receptor agonist, TRK-820.

31 March 2024

786

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Efferent projections from the striatal patch compartment: anterograde degeneration after selective ablation of neurons expressing mu-opioid receptor in rats

31 March 2024

787

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

G-protein-gated potassium channels containing Kir3.2 and Kir3.3 subunits mediate the acute inhibitory effects of opioids on locus ceruleus neurons.

31 March 2024

788

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Comparison of morphine and kainic acid microinjections into identical PAG sites on the activity of RVM neurons

31 March 2024

789

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Predominance of delta-opioid-binding sites in the porcine enteric nervous system

31 March 2024

790

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The role of spinal neuropeptides and prostaglandins in opioid physical dependence

31 March 2024

791

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Relationship between rate and extent of G protein activation: comparison between full and partial opioid agonists

31 March 2024

792

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The antinociceptive properties of endomorphin-1 and endomorphin-2 in the mouse

31 March 2024

794

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Delta opiates increase ischemic tolerance in isolated rabbit jejunum

31 March 2024

795

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Low-dose dexamethasone reduces nausea and vomiting after epidural morphine: a comparison of metoclopramide with saline

31 March 2024

796

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Lack of sensitization during place conditioning in rats is consistent with the low abuse potential of tramadol

31 March 2024

797

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Involvement of mu(1)-opioid receptors and cholinergic neurotransmission in the endomorphins-induced impairment of passive avoidance learning in mice

31 March 2024

798

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effects of U-50,488H, a kappa-opioid receptor agonist, on the learned helplessness model of depression in mice

31 March 2024

799

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effects of 14-methoxymetopon, a potent opioid agonist, on the responses to the tail electric stimulation test and plus-maze activity in male rats: neuroendocrine correlates

31 March 2024

800

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Boosting effect of morphine on alcohol drinking is suppressed not only by naloxone but also by the cannabinoid CB1 receptor antagonist, SR 141716.

31 March 2024

801

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Opioidergic effects of nonopioid analgesics on the central nervous system

31 March 2024

803

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The effects of analgesia in the vulnerable infant during the perinatal period.

31 March 2024

804

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Prenatal opiate exposure: long-term CNS consequences in the stress system of the offspring

31 March 2024

805

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Differential effects of prenatal morphine exposure on analgesia produced by vaginocervical stimulation or systemic morphine administration in adult rats

31 March 2024

806

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Endomorphin-2 inhibits GABAergic inputs to cardiac parasympathetic neurons in the nucleus ambiguus

31 March 2024

807

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Nociceptin inhibits gamma-aminobutyric acidergic inputs to cardiac parasympathetic neurons in the nucleus ambiguus

31 March 2024

808

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Allelic variation in the human prodynorphin gene promoter and schizophrenia.

31 March 2024

809

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Spinal nociceptin inhibits septide but not N-methyl-D-aspartate-induced nociceptive behavior in rats

31 March 2024

810

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Differential effects of chronic antidepressant treatments on micro- and delta-opioid receptors in rat brain.

31 March 2024

811

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Review article: the concept of entero-colonic encephalopathy, autism and opioid receptor ligands

31 March 2024

813

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Endocannabinoids in pain modulation

31 March 2024

814

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Conditioned opioid withdrawal decreases nociceptin/orphanin FQ levels in the frontal cortex and olfactory tubercle

31 March 2024

815

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Infralimbic kappa opioid and muscarinic M1 receptor interactions in the concurrent modulation of anxiety and memory

31 March 2024

816

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Orphanin FQ/nociceptin and mu-opioid receptor mRNA levels in human SH-SY5Y neuroblastoma cells: effects of activating the cAMP-PKA signal transduction pathway

31 March 2024

817

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade

31 March 2024

818

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effects of lesions of various brain areas on drug priming or footshock-induced reactivation of extinguished conditioned place preference

31 March 2024

819

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Identification of two C-terminal amino acids, Ser(355) and Thr(357), required for short-term homologous desensitization of mu-opioid receptors

31 March 2024

820

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Mu- and delta-opioid receptor mRNAs are expressed in periaqueductal gray neurons projecting to the rostral ventromedial medulla

31 March 2024

821

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Mu-opioid receptor mediates chronic restraint stress-induced lymphocyte apoptosis

31 March 2024

823

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The prophylactic effect of tropisetron on epidural morphine-related nausea and vomiting: a comparison of dexamethasone with saline

31 March 2024

824

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Endomorphin-2 immunoreactivity in the cervical dorsal horn of the rat spinal cord at the electron microscopic level

31 March 2024

825

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Uterus-innervating neurones of paracervical ganglion in the pig: immunohistochemical characteristics

31 March 2024

826

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats

31 March 2024

827

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effects of excitotoxic lesions of the central or basolateral nucleus of the amygdala on naloxone-precipitated withdrawal-induced conditioned place aversion in morphine-dependent rats

31 March 2024

828

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Regulation of opioid receptor expression

31 March 2024

829

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Running increases ethanol preference

31 March 2024

830

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Delta FosB regulates wheel running.

31 March 2024

831

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Stress-induced preproenkephalin mRNA expression in the amygdala changes during early ontogeny in the rat.

31 March 2024

832

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The role of spinal cholecystokinin in chronic pain states

31 March 2024

833

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Endogenous opioid regulation of stress-induced oxytocin release within the hypothalamic paraventricular nucleus is reversed in late pregnancy: a microdialysis study

31 March 2024

834

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Modulation of the locomotor properties of morphine and amphetamine by uncontrollable stress

31 March 2024

836

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Pharmacogenetics of codeine metabolism in an urban population of children and its implications for analgesic reliability

31 March 2024

837

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effects of cool and hot humid environmental conditions on neuroendocrine responses of horses to treadmill exercise

31 March 2024

838

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Sex differences in delta opioid receptor immunoreactivity in rat medial amygdala

31 March 2024

839

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Identification of quantitative trait loci for chemical/inflammatory nociception in mice.

31 March 2024

840

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Virally mediated delivery of enkephalin and other neuropeptide transgenes in experimental pain models

31 March 2024

841

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Pluronic p85 block copolymer enhances opioid peptide analgesia

31 March 2024

842

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Loss of intrathecal morphine analgesia in terminal cancer patients is associated with high levels of excitatory amino acids in the CSF.

31 March 2024

843

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Role of kappa opioid receptor in cardioprotection of preconditioning: implications in cardiac surgery

31 March 2024

844

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Roles of endogenous opioid peptides in modulation of nocifensive response to formalin

31 March 2024

845

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Spinal pretreatment with antisense oligodeoxynucleotides against exon-1, -4, or -8 of mu-opioid receptor clone leads to differential loss of spinal endomorphin-1-and endomorphin-2-induced antinociception in the mouse

31 March 2024

846

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Blockade of ionotropic glutamatergic transmission in the ventral tegmental area reduces heroin reinforcement in rat.

31 March 2024

847

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

GABAergic mechanisms of heroin-induced brain activation assessed with functional MRI.

31 March 2024

848

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Intrathecal [Nphe1]nociceptin(1-13)NH2 selectively reduces the spinal inhibitory effect of nociceptin

31 March 2024

849

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Pharmacological profiles of a novel opioid receptor-like1 (ORL(1)) receptor antagonist, JTC-801

31 March 2024

850

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Spinorphin as an endogenous inhibitor of enkephalin-degrading enzymes: roles in pain and inflammation

31 March 2024

851

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

In vitro stability and in vivo pharmacokinetic studies of a model opioid peptide, H-Tyr-D-Ala-Gly-Phe-D-Leu-OH (DADLE), and its cyclic prodrugs

31 March 2024

853

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Morphine microinjections into the rat nucleus submedius depress nociceptive behavior in the formalin test

31 March 2024

854

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Dextromethorphan attenuates morphine withdrawal syndrome in neonatal rats passively exposed to morphine

31 March 2024

855

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Opioid peptides and the control of human ingestive behaviour

31 March 2024

856

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Inhibition of muscimol on morphine-induced hyperactivity, reverse tolerance and postsynaptic dopamine receptor supersensitivity

31 March 2024

857

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Inhibition of THIP on morphine-induced hyperactivity, reverse tolerance and postsynaptic dopamine receptor supersensitivity

31 March 2024

858

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effect of 6-hydroxydopamine treatment in the area postrema on morphine-induced emesis in ferrets

31 March 2024

859

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Involvement of endogenous opioid systems in nociceptin-induced spinal antinociception in rats

31 March 2024

860

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Addition of meperidine to bupivacaine for spinal anaesthesia for Caesarean section

31 March 2024

861

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Two variables that can be used as pain indices in experimental animal models of arthritis

31 March 2024

862

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Transcutaneous electrical acupoint stimulation potentiates analgesic effect of morphine

31 March 2024

863

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Electrophysiological effects of morphine in an in vitro model of the 'border zone' between normal and ischaemic-reperfused guinea-pig myocardium.

31 March 2024

864

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Isolation and distribution of endomorphins in the central nervous system

31 March 2024

865

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Naltrexone, an opioid antagonist, facilitates reepithelialization of the cornea in diabetic rat.

31 March 2024

866

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The biology of the opioid growth factor receptor (OGFr)

31 March 2024

867

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Rewarding and psychomotor stimulant effects of endomorphin-1: anteroposterior differences within the ventral tegmental area and lack of effect in nucleus accumbens.

31 March 2024

868

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Impaired release of beta-endorphin in response to serotonin in a rat model of depression

31 March 2024

869

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effect of imipramine on the expression and acquisition of morphine-induced conditioned place preference in mice

31 March 2024

870

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Dopamine receptor mechanism(s) and morphine tolerance in mice

31 March 2024

871

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effects of histamine and opioid systems on memory retention of passive avoidance learning in rats

31 March 2024

872

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The effects of dopamine receptor agents on naloxone-induced jumping behaviour in morphine-dependent mice

31 March 2024

873

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

The effects of simultaneous administration of alpha(2) -adrenergic agents with L-NAME or L-arginine on the development and expression of morphine dependence in mice

31 March 2024

874

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Influence of nitric oxide on morphine-induced conditioned place preference in the rat central amygdala

31 March 2024

875

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effects of adrenoceptor agonists and antagonists on morphine-induced Straub tail in mice

31 March 2024

876

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Nicotine potentiation of morphine-induced catalepsy in mice

31 March 2024

877

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Changes in mu opioid receptors and rheological properties of erythrocytes among opioid abusers

31 March 2024

878

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Reinforcing effect of subcutaneous morphine in a modified Ettenberg runway

31 March 2024

879

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Novel, potent ORL-1 receptor agonist peptides containing alpha-Helix-promoting conformational constraints

31 March 2024

880

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

(-)U50,488H [(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]benzeneacetamide] induces internalization and down-regulation of the human, but not the rat, kappa-opioid receptor: structural basis for the differential regulation

31 March 2024

881

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Role of nitric-oxide synthase, free radicals, and protein kinase C delta in opioid-induced cardioprotection

31 March 2024

882

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Neuroprotective role of delta-opioid receptors in cortical neurons.

31 March 2024

883

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Intake of saccharin, salt, and ethanol solutions is increased by infusion of a mu opioid agonist into the nucleus accumbens

31 March 2024

884

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effect of prodynorphin-derived opioid peptides on the ovulatory luteinizing hormone surge in the proestrous rat.

31 March 2024

885

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Profound spinal tolerance after repeated exposure to a highly selective mu-opioid peptide agonist: role of delta-opioid receptors

31 March 2024

886

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effect of orphanin FQ on interleukin-1beta mRNA transcripts in the rat CNS.

31 March 2024

888

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effects of scopolamine and physostigmine on acquisition of morphine-treated rats in Morris water maze performance

31 March 2024

889

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Role of protein kinase C-epsilon in the development of kappa-opioid receptor tolerance to U50,488H in rat ventricular myocytes

31 March 2024

890

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Injection of substance P (SP) N-terminal fragment SP(1-7) into the ventral tegmental area modulates the levels of nucleus accumbens dopamine and dihydroxyphenylacetic acid in male rats during morphine withdrawal

31 March 2024

891

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effects of acute "binge" cocaine on preprodynorphin, preproenkephalin, proopiomelanocortin, and corticotropin-releasing hormone receptor mRNA levels in the striatum and hypothalamic-pituitary-adrenal axis of mu-opioid receptor knockout mice

31 March 2024

892

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Navigation in the Morris swim task as a baseline for drug discrimination: a demonstration with morphine

31 March 2024

893

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

mu-opioid receptor-mediated antinociceptive responses differ in men and women.

31 March 2024

894

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Gender differences in narcotic-induced emesis in the ED.

31 March 2024

895

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

Effect of MK-801 on the antinociceptive effect of [D-Ala(2),N-MePhe(4), Gly-ol(5)]enkephalin in diabetic mice

31 March 2024

896

1 reference

https://api.crossref.org/works/10.1016/J.PEPTIDES.2003.08.002

31 March 2024

Identifiers

1 reference

9 August 2017

1 reference